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Cellular processes are carried out by proteins, which often utilize conformational 
changes for function. In theory, conformational changes can be harnessed to promote, 
prevent or monitor cellular processes. Such changes in protein active centers require 
perturbations through interactions with other proteins, small molecules or through energy 
input into the system, for example light. The work presented incorporates rational design 
and crystallographic elucidation of two-state conformational changes in two proteins, 
green fluorescent protein (GFP) and malate synthase (MS). 
GFP indicators were previously developed to quantitate the thiol/disulfide redox 
status within cells. Cysteine residues were introduced in close proximity on the surface 
of GFP and allow the formation of a disulfide bond. The indicators provide a fluorescent 
readout of the ambient thiol/disulfide equilibrium, however thermodynamic studies 
showed the resulting thiol/disulfide to be unusually stable (-287 mV) in comparison to 
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the cellular redox buffer glutathione (-240 mV). In order to produce a family of redox 
indicators suitable for use in less reducing environments, amino acids were inserted near 
the introduced cysteine pair in order to destabilize the disulfide. The resulting family of 
redox indicators, termed roGFP-iX, exhibit midpoint potentials in the more desirable 
range of -229 to -246 mV. Crystallographic analysis indicates that roGFP-iX indicators 
undergo much larger two-state conformational changes than the original indicators. 
Surprisingly, a cis-peptide was discovered between the cysteine and the inserted residue 
which in combination with the conformational changes helps to explain the reduced 
stability of the disulfide. 
Malate synthase is an important virulence factor for certain microbes and carries 
out the Claisen condensation between glyoxylate and acetyl-CoA to produce malate. 
Crystal structures ofMycobacterium tuberculosis and Escherichia coli malate synthase 
isoform G had previously been determined with substrates or products bound. To 
determine the conformational changes necessary for substrate binding and product 
release, crystal structures of Escherichia coli malate synthase isoform A were determined 
in both the apo and acetyl-CoA/inhibitor bound forms. The crystallographic models 
revealed two-state conformational changes in the part of the active-site loop necessary for 
substrate binding, which has important implications for drug design. 
This dissertation includes my unpublished co-authored materials. 
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CHAPTER I 
INTRODUCTION 
OVERVIEW 
I was initially interested in the proteins malate synthase (MS) and green 
fluorescent protein (GFP) for two very different reasons. The enzyme MS is important 
for the growth and survival of microbes, several of which are pathogenic; therefore the 
study of this enzyme has implications in drug design and human health. MS also carries 
out a difficult carbon-carbon bond forming reaction during catalysis, which is an 
interesting problem in enzyme chemistry. GFP is a wonderfully unique protein that 
allows molecular and cellular biologists to probe the inner workings of cells with a 
convenient fluorescent readout. Practically, my interest in GFP was in its utility as a 
biosensor, specifically in expanding its range as a sensor for cellular thiol/disulfide 
equilibrium. As X-ray crystallographic studies on these two projects unfolded, the 
appearance of important two-state conformational changes near the area of chemical 
activity (active center) in each protein became readily apparent. In this chapter, protein 
conformational changes are discussed with respect to enzymes and information 
transducing proteins (biosensors). Also a brief history of MS and GFP is presented. 
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PROTEIN CONFORMATIONAL CHANGES 
When proteins interact with each other or with small molecules, or are perturbed 
by energy input into the system (e.g. light), the three dimensional structure is sometimes 
dramatically affected through conformational changes. These changes can involve large 
parts of the protein such as domains or be localized to particular active centers. 
Conformational changes are implied by the function ofmany proteins, even without 
direct evidence. For example, G protein-coupled receptors (GPCR) bind or "sense" 
molecules on the outside of the cell and must transmit that signal to the interior of the cell 
(1). Upon ligand binding, an induced conformational change is transmitted from the 
extracellular domain through the transmembrane domain and to the cytoplasmic domain 
producing a cellular response. Without this conformational change, the presence of the 
ligand would be only felt on the outside of the cell. 
Proteins use conformational changes to achieve many different cellular functions, 
from catalysis to information transduction. An example of signal transduction from 
outside to inside the cell has already been presented with the GPCRs. Another set of 
signal transduction proteins are transcription factors such as OxyR, which undergoes a 
conformational change upon oxidation by H202 and reactive oxygen species (ROS) to 
accomplish gene regulation (2, 3). The cellular "energy currency" molecule, adenosine 
triphosphate (ATP), is produced when ATP synthase converts an electrochemical 
gradient into mechanical protein conformational changes (4). Many other proteins use 
ATP as the energy to drive the conformational changes necessary for function, such as 
for building actin filaments (5) or in the myosin molecular motors that utilize the 
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filaments to produce movement (6). An underlying theme is the interaction of proteins 
with a small molecule. The interactions with enzymes and signal-transducing proteins 
will be discussed in detail below. 
Many techniques are available to study conformational changes in proteins, each 
with their strengths and limitations. The highest resolution structural information can be 
acquired using X-ray crystallography, which describes the endpoints of the 
conformational changes in atomic detail. X-ray crystallography reveals only the states 
before and after conformational changes, making the models are inherently two-state. 
NMR has the added benefit of being able to assign time constants to the changes, but in 
many cases, it lacks the structural accuracy of crystallography. When proteins are not 
amenable to crystallization or analysis by NMR, fluorescence resonance energy transfer 
(FRET) and cryo-electron microscopy can be useful but are limited to large 
conformational changes (such as domain movement). 
ENZYME FUNCTION AND CONFORMATIONAL CHANGES 
The observation that proteins can be crystallized introduced the idea that proteins 
are discrete molecules with well-defined structures. Previously, Emil Fischer in 1894 
proposed the lock-and-key model for catalysis, where an enzyme and substrate interact 
with no change in conformation (7). In this model, the substrate and protein have 
complementary shapes that fit together precisely, which explains enzyme specificity. 
However, the model lacks in explaining how substrate binding would lead to transition 
state stabilization, which is necessary for catalysis. In reality proteins are inherently 
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flexible an idea better captured by Daniel Koshland's 1954 model of induced-fit (8). 
Briefly, a protein and substrate initially bind weakly and after conformational changes 
binding affinity is maximal. These conformational changes can strain a substrate to 
promote catalysis, or place the side chains of residues in the proper orientation for 
catalysis that may not have been favorable for initial substrate binding. Some enzymes 
also use conformational changes to modulate function, as observed with allosteric 
binding. In metabolism, many enzymes are inhibited by metabolites downstream of the 
products they produce to prevent intermediates from building up. A specific example is 
phosphofructokinase-1, whose products feed into the citric acid cycle, yet is inhibited by 
citrate binding to a site away from the active site (9). In such cases, drugs can be 
designed to inhibit enzyme function either through direct binding to the active site 
(transition-state analogs) or at allosteric sites, which may not always be naturally 
occurring. Indeed, the ultimate purpose of my work on MS has been to improve the 
chances that effective inhibitors can be identified. 
MALATE SYNTHASE 
The ability of some microbes to grow solely on acetate interested some scientists 
and lead them to the discovery of malate synthase, which was first purified in 1956 from 
Escherichia coli grown in media containing acetate (10). The study of MS is important 
as it and the enzyme isocitrate lyase form the basis ofthe glyoxylate cycle, a modified 
citric acid cycle that allows microbes to grow on acetate and other two-carbon molecules 
(11). MS catalyzes a magnesium-dependent carbon-carbon bond-forming reaction 
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between acetyl-CoA and glyoxylate yielding malate. Citrate synthase (CS) catalyzes a 
similar carbon-carbon bond forming reaction between acetyl-CoA and oxaloacetate, but 
is independent ofmagnesium (12). The complete lack of sequence similarity between CS 
and MS provoked Howard et al. (13) to solve the structure ofEscherichia coli malate 
synthase isoform G from (ecMSG). These studies were performed to elucidate whether 
the reaction mechanisms were similar and determine how proteins with so little sequence 
similarity can carry out a similar reaction. 
Previous structural studies showed CS to be almost completely a-helical (12). 
Structural studies by Howard et al. showed that CS and MS structures were indeed very 
different (13). The active site ofMS is sandwiched between a mostly a-helical domain 
and a TIM barrel, which is made of alternating a-helices and ~-sheets. This MS structure 
had glyoxylate bound and showed that CS and MS differ in the mode of activation of the 
electrophilic substrate, with two histidines in CS replaced by an arginine and magnesium. 
Further structural and mutagenic studies by Anstrom et al. on ecMSG confirmed that both 
MS and CS utilize an aspartate for the deprotonation of acetyl-CoA (14). While the exact 
mechanisms of MS and CS differ, the strategies involved remain similar. 
Interestingly, CS structural studies showed that there was a large conformational 
change between the apo and substrate bound structures, whereby the binding of 
oxaloacetate induces the protein to form a binding site for acetyl-CoA (12). Previous 
small angle X-ray scattering (15) and circular dichroism (16, 17) experiments on MS 
indicated that the binding of glyoxylate, like the binding of oxaloacetate in CS, induces 
conformational changes. To explain the putative conformational change it was proposed 
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that the important domains of ecMSG would separate to allow the active site to sequester 
reactants from solution (13). NMR studies of ecMSG later refuted this idea (18). Given 
that crystals of ecMSG are difficult to grow, I searched for a MS more amenable to 
crystallographic studies, in the hope of finding the conformational changes upon substrate 
binding thus aiding drug design. The results of the search are reported in chapter III. 
SIGNAL TRANSDUCTION AND CONFORMATIONAL CHANGES 
The transfer of information in a cell is of utmost importance to maintaining 
cellular homeostasis. For a protein to transmit a signal, such as the presence of a 
molecule, the protein must first bind the molecule followed by a conformational change, 
as without the change there would be very little a protein could do to achieve cellular 
responses. Substrate binding often changes the structure in order for the protein to have 
another function, such as binding to DNA or other proteins and in the process 
information is transferred. Transcription factors such as nuclear hormone receptors are 
cytoplasmic and upon hormone binding are translocated into the nucleus where they 
change patterns of gene regulation (19). Specifically, the hormone receptors are partially 
unfolded and require chaperones for solubility. When the hormone binds, the nuclear 
receptor undergoes a conformational change from the unfolded to a folded state. 
Likewise, calmodulin undergoes a conformational change when it binds to calcium (20), 
at which point it can bind to many different proteins and regulate their function. In 
combination with fluorescent proteins, conformational changes in many proteins have 
been exploited to develop sensors. 
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FLUORESCENT PROTEIN BASED BIOSENSORS 
The discovery and cloning of the green fluorescent protein from Aequorea 
victoria has revolutionized cellular biology. GFP is a protein that contains a 
chromophore that is produced auto-catalytically from a -S-Y-G- sequence in the center of 
the folded protein (21). Since chromophore production occurs without the need of 
external cofactors, GFP can be fused with other proteins to monitor the cellular 
localization of the fusion protein in real time. The power of GFP as a cellular marker led 
to the development and discovery of a whole rainbow of fluorescent proteins (FP). 
With multiple FPs available, the development of completely genetically encoded 
FRET biosensors became possible. Such biosensors employ a donor, usually a blue or 
cyan FP that is excited at UV-blue wavelengths, and emits near the peak of an acceptor, 
usually a green or yellow FP. When the FPs are in close proximity, excitation of the 
donor leads to fluorescence from the acceptor. By contrast, when they are far apart, 
emission comes from the donor, and the ratio between the emission intensities gives rise 
to the FRET signal. Conformational changes in various proteins fused between the FPs 
alter the distance and/or orientation between the donor and acceptor, thus changing the 
FRET signal. One of the greatest powers of FRET systems is that the signal is inherently 
ratiometric. Because the emission peaks interconvert, changes in cell thickness and other 
factors cancel out. One of the first FRET biosensors demonstrated was through a 
calmodulin fusion, which was developed almost simultaneously by Romoser et al. (22) 
and Miyawaki et al. (23) in 1997. The number of these sensors has grown quickly since 
their first implementation. One group reports in a symposium abstract the production of 
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"redoxifluor", using of the redox sensitive domain of a yeast transcription factor, Yaplp, 
to produce a FRET sensor, but as of now no further reports have been made (24). 
Another group produced a redox-sensitive FRET sensor using the redox regulated 
domain ofHSP-33 and appropriately coined it HSP-FRET (25). Studies of HSP-FRET in 
cardiomyocytes showed that after oxidation, reduction of the probes was a very slow 
process, which limits the utility of the system. Fortunately, FRET based systems are not 
the only way to make a fluorescent biosensor. 
The excitation spectrum of OFP displays two peaks, which correspond to the 
neutral and anionic forms of the chromophore (21). This makes OFP an inherently two­
state protein. Our job is to manipulate the inherent chromophore equilibrium of OFP to 
produce a biosensor. In many cases biosensors have been produced using OFP which 
preserve both excitation peaks, and in some cases perturbation results in the 
interconversion of the peaks which makes these sensors ratiometric. Some groups have 
utilized circularly permuted variants of OFP to produce sensors, for example inserting 
calmodulin into the barrel of OFP next to the phenolic end of the chromophore produced 
a sensor whose excitation spectra was dependent upon calcium binding (26). Similarly, 
OxyR and its conformational change were used to make a H202 sensor (27). All of the 
previously described sensors utilize the conformational changes in other proteins linked 
to FPs to change the signal. Modification of OFP through mutagenesis can produce 
simpler sensors. 
Some of the first attempts to change the excitation and emission spectra of OFP 
led to variants whose chromophore protonation state was pH dependent. Some of these 
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mutants, discovered by Hanson et aI., exhibited ratiometric dual color emission properties 
and were named deGFP for short (28). Crystal structure analysis of deGFP revealed that 
a strand near the chromophore undergoes a large conformational change between high 
and low pH. Redox sensitive GFP (roGFP) developed by Hanson et ai. has a very small 
conformational change before and after its reaction with small redox molecules, which is 
partly responsible for its thiolldisulfide equilibrium properties (29). The second chapter 
reports the development of a roGFP with different thiolldisulfide equilibrium properties 
due to much larger engineered conformational changes. 
Chapter II and III include previously unpublished co-authored materials. 
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CHAPTER II 
DEVELOPMENT OF A FAMILY OF REDOX-SENSITIVE GREEN
 
FLUORESCENT PROTEIN INDICATORS FOR USE IN RELATIVELY
 
OXIDIZING SUBCELLULAR ENVIRONMENTS
 
Experimental data presented in this chapter are my own with some data collection 
done by Josef Heenan. I prepared the original manuscript. Jim Remington provided 
direction, support and extensively edited the manuscript. 
SUMMARY 
Green fluorescent protein (GFP) indicators have previously been developed that 
rapidly and quantitatively respond to changes in the thiol/disulfide equilibrium within 
subcellular compartments. In these indicators, surface exposed cysteines residues were 
introduced so as to form a redox-active disulfide that in turn controls the emission 
properties of the internal chromophore. The biosensors have been shown to be effective 
reporters of the thiol/disulfide status within reducing compartments such as the 
mitochondria and cytosol for several cell types. However, due to the unusual 
thermodynamic stability of the introduced disulfide bond, the indicators are not useful for 
quantitative analysis within more oxidizing compartments such as the endoplasmic 
.----- -----------------
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reticulum. Here we report the development of a new family of GFP-based redox 
indicators in which the thermodynamic stability of the disulfide has been substantially 
lowered by insertion ofa single amino acid into the main chain, adjacent to cysteine 147. 
The insertions result in indicators with midpoint potentials of -229 to -246 mV, and are 
thus better suited for study of relatively oxidizing subcellular compartments. High 
resolution crystallographic models of two variants highlight how the structure of the 
disulfide is perturbed by the presence of the insertion and give new insight into the 
factors which influence the thermodynamic stability of a reactive disulfide. 
INTRODUCTION 
Previously developed redox-sensitive green fluorescent proteins are effective 
indicators of cellular thiol/disulfide equilibrium. The indicators were produced by 
substitution of cysteines residues on the surface of GFP where they form a disulfide bond 
without substantially distorting the structure of the protein. On a background ofwild­
type or S65T GFP, Hanson et al. substituted cysteines residues at positions Ser147 and 
Gln204 (to create roGFPl and roGFP2, respectively) or Asn146 and Ser202 (to create 
roGFP3 and roGFP4, respectively) (29). Using the same approach but on the background 
of the yellow fluorescent GFP variant YFP (Aemmax = 525 nm), Ostergaard et al. produced 
rxYFpNC, where N and C indicate the locations of the introduced cysteines (30). 
In vitro and in vivo, these two families of indicators show two-state changes in 
fluorescence excitation in response to the thiolldisulfide ratio. As determined by simple 
titrations against thiol/disulfide redox buffers such as DDT or lipoic acid, the midpoint 
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potentials ofroGFPl, roGFP2 and rxYFp149202 (which contain the same reactive 
disulfide) have been reported to be -287, -272 (29) and -261 mV (30), respectively. 
Compared to the midpoint potential of the GSSG-GSH couple (-240 mV (31)), these 
indicators are quite reducing and are thus best suited for use in reducing subcellular 
environments. roGFP indicators are ratiometric by excitation, that is, they exhibit two 
excitation peaks (~390 and 475 nm), corresponding to the neutral and an anionic 
chromophore forms, respectively. Excitation of either peak gives rise to green 
fluorescence at about 510 nm. Upon oxidation of the redox-sensitive disulfide, the 
population of the neutral chromophore is favored at the expense of the anionic 
chromophore, demonstrating two-state behavior. In contrast, rxYFPs have a single 
fluorescence excitation peak (at ~512 nm) which varies in amplitude with oxidation and 
thus these indicators are not ratiometric. However, most other properties are very similar. 
roGFPs and rxYPPs have been expressed in a variety of cell types. roGFP 
indicators were used to determine the thiol/disulfide equilibrium within the mitochondria 
(EpH=8 ~ -360 mV) (29) and cytoplasm (EpH=7 ~ -320 mV) (32) of single HeLa cells, as 
well in Arabidopsis (mitochondria EpH=7,8 -362±10 mV and cytoplasm EpH=7 -318±13 mV 
(33)). The cytosolic thiol/disulfide equilibrium of Saccharomyces cerevisiae and 
Escherichia coli has been determined using rxYFp149202 and shown to be -289 mV and­
259 mV respectively (30, 34). However, the disulfide bonds of all of these probes are too 
stable to allow the measurement of the redox potential in more oxidizing environments 
such as the endoplasmic reticulum (estimated EO' -180±6 mV (35)), where all of the 
probes are completely oxidized (34, 36, 37). Austin et al. (37) used this feature of 
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roGFP 1 to determine that, contrary to the prevailing misconception, the endocytotic 
pathway in human prostate cancer PC3 cells is oxidizing, however a quantitative result 
was not reported. 
Thus, there is a clear need to extend the range of midpoint potentials over which 
redox-sensitive GFPs can be used as quantitative reporters. One attractive approach to 
extend this range is to reengineer existing GFP-based indicators so as to lower the 
thermodynamic stability of the reactive disulfide. In nature, midpoint potentials of 
protein disulfides are found to cover an extremely large range that spans the relevant 
physiological states. Considering only those proteins that are catalytically active in 
establishing thiol/disulfide equilibrium processes, the midpoint potentials of the 
thiol/disulfide oxidoreductases range from -270 mV for E. coli thioredoxin (38) to -122 
mV DsbA (39). This range corresponds to a difference of approximately three orders of 
magnitude in the equilibrium constants for disulfide formation. 
From studies of the thiol/disulfide oxidoreductases (40), peptides and small 
dithiol-containing molecules (41, 42) it is clear that several factors affect the 
thermodynamic stability of disulfides, including thiol pKa, geometric strain and entropic 
effects. Approaches to modify disulfide stability could in principle make effective use of 
anyone or combination of these factors. One approach to reduce disulfide stability is to 
decrease the pKa of one or both of the participating thiols, which stabilizes the reduced 
state by making the thiol a better leaving group (43). In practice this has been achieved 
in proteins by substitution of one or more positively charged residues close to the reactive 
disulfide, which in principle would stabilize a negative charge on the thiolate. Such an 
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approach has been studied in detail for roGFPl (44) and rxYFP147202 (45). In roGFPl, 
substitution of three arginine or lysine residues near the disulfide increased the midpoint 
potential by 16mV. In roGFPl, the substitutions had the added effect of increasing the 
rates of oxidation and reduction, for a 4.9 fold increase in oxidation rate constant by H202 
and 6.0 fold increase in the DTT reduction rate constant. Similarly, placement of three 
arginine residues near the disulfide of rxYFp147202 led to a 4.3 fold increase in the rate of 
oxidation by p-mercaptoethanol and 13 fold increase in the rate of oxidation by GSSG 
(the changes in indicator midpoint potentials were not reported). The latter results 
suggest that at least part of the observed rate increase can be attributed to electrostatic 
effects on substrate diffusion. 
Two other approaches to reduce disulfide stability are to increase geometric strain 
in the oxidized state and to change entropic factors associated with the reaction. These 
may be linked. For example, in small molecules that undergo ring closure upon disulfide 
fonnation, decreasing the ring size below six atoms increases the midpoint potential 
because the disulfide cannot achieve the lowest energy geometry, whereas increasing the 
ring size above six increases the entropic barrier to disulfide fonnation. The latter effect 
may also be thought of as lowering the effective concentration of the reacting species (46, 
47). There is a similar relationship for peptides containing cysteine residues. Cysteines 
that are immediately adjacent to each other or separated by one intervening residue do not 
readily fonn disulfides, which is thought to be due to geometric strain, but beyond a 
certain size, increasing the length of the peptide decreases disulfide stability due to 
entropic effects (43, 48-50). 
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In proteins, the addition or deletion of residues flanking the disulfide may 
additionally increase or decrease disulfide stability, depending upon how the protein 
rearranges to accommodate the insertion or deletion. In one example, the deletion of the 
proline from the active site peptide -CPGC- to produce -CGC- in thioredoxin 
destabilized the disulfide bond (towards a more oxidizing potential) to ~-200 mV versus ­
270 mV for wild-type as determined by the non-equilibrium with NADH/NAD+ via 
thioredoxin reductase (51). The inherent instability of the CGC peptide (-167 mY) is 
suggested to be the reason behind the large change in midpoint potential of the -CGC­
thioredoxin (51). 
Here we describe efforts to use single amino acid insertions to destabilize the 
redox-sensitive disulfide bridge of a redox-sensitive GFP, in order to produce a roGFP 
suitable for relatively oxidizing subcellular environments. An additional requirement 
was that the roGFP exhibit ratiometric response to changes in the ambient thiolldisulfide 
equilibrium. Equilibrium and kinetic measurements indicate that for one class of insertion 
mutants (roGFPl-iX), the disulfide is substantially destabilized, showing higher rates of 
reduction and lower rates of oxidation compared to the parent molecule roGFP1. Crystal 
structure analysis of two variants in the oxidized and reduced states verified disulfide 
formation in the oxidized state and revealed large conformational changes associated 
with oxidation/reduction. The factors contributing to disulfide stability are discussed in 
the light of the atomic models. 
16 
METHODS AND MATERIALS 
Experimental approach and mutational analysis 
Initially, we chose to insert a single glycine residue on either side of the cysteine 
residues (147 and 204) participating in the redox-sensitive disulfide ofroGFP1 and 
roGFP2. Glycine has the fewest restrictions on backbone conformation and thus in 
principle the insertion could be accommodated by the protein in a variety of ways. 
Glycine-containing mutants, four for each roGFP 1 and roGFP2, were produced and 
purified; those shown to have spectra sensitive to addition of reductants were 
characterized further by titration against DTT and lipoic acid. Of those that were 
characterized, none exhibited a response that was ratiometric by excitation; having only a 
general increase in fluorescence upon reduction, similar to rxYFP. However one variant, 
roGFP2 with glycine insertion C-terminal to Cys147 (roGFP2-147CG), was found by 
titration to have a thermodynamically destabilized disulfide. This variant was then 
subjected to random and directed mutagenesis with two objectives in mind. The first 
objective was to produce a variant with ratiometric response to changes in the ambient 
thiol/disulfide equilibrium, while the second objective was to investigate the 
consequences of side chain size and charge at the insertion position on the 
thermodynamic stability of the disulfide linkage. 
As it is well known that wild-type GFP does not fold efficiently at 37° C (21), 
before random mutagenesis was initiated, the so-called "folding mutations" [F64L, F99S, 
M153T, V163A and I167T, see references (21, 52, 53)] were incorporated into roGFP2­
147CG and roGFP1-147CG to increase the likelihood of detection of random mutants 
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which retain fluorescence. Residues near the putative disulfide and known to influence 
the protonation state of the chromophore (Gly147a, His148, Thr203 and Ser205) were 
chosen for randomization in those backgrounds. Bacterial colonies expressing visibly 
fluorescent protein were picked, sequenced, expressed in small quantities overnight and 
finally subjected to SDS-PAGE analysis to assess aggregation under oxidizing 
conditions. Those variants which formed dimers or higher aggregation states were 
rejected. Variants which survived this selection were then further characterized by 
fluorescence spectroscopy. 
Gene construction, mutagenesis and protein expression/purification 
Fluorescent proteins in plasmid pQE-30 are expressed constitutively in E. coli 
DH5a cells, for that reason roGFP1 (GFP with C48S/S 147C/Q204C) in pRSETB was 
PCR amplified using primers containing BamHI and HindIII cut sites and cloned into 
pQE-30 containing an N-terminal His6 tag. To produce the initial insertions and all other 
non-random mutations the QuikChange (Stratagene) protocol was utilized. 
Random mutants were produced using the Stratagene Multi-Site Directed 
Mutagenesis kit and transformed into DH5a cells. Two primers were utilized one 
randomizing positions Gly147a and His148 simultaneously and the other primer 
randomizing positions Thr203 and Ser205. Colonies expressing random mutants were 
screened by placing the plates on a UV-transilluminator and selecting colonies which 
were visibly fluorescent. These colonies were used to inoculate 2 mL of growth media, 
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after growth overnight the bacteria were harvested and plasmids purified. DNA 
sequencing of the GFP coding region was used to identify all mutants. 
roGFP 1 and the initial insertion mutants were prepared from pRSETB plasmids as 
described previously (29, 44) and require expression at 18-22°C. Random insertion 
mutants in plasmid pQE-30 were expressed in E. coli strain DH5a by allowing cultures to 
reach an OD600 of between 0.4 and 0.9 growing at 37°C, at which point the temperature 
was reduced to 25°C overnight, no IPTG was needed for efficient protein production. 
Cells were pelleted by centrifugation and resuspended in 50mM HEPES (pH 7.9), 
300mM NaCI and 10% glycerol. The cells were frozen, thawed and then sonicated for 5 
min. Cell lysate was centrifuged and the supernatant was applied to a column ofNi2+_ 
agarose resin (Qiagen) for purification. Samples were dialyzed into 20mM Tris (pH 8.0), 
ImM EDTA and further purified using anion exchange. Pure fractions were concentrated 
by filtration and buffer exchanged into 20mM HEPES (pH 7.9). 
Midpoint potential determinations 
To minimize 02-mediated oxidation all solutions and samples were 
prepared/incubated in an anaerobic glove-box. Protein samples were prepared at ~ 1 IlM 
in 100 mM HEPES (pH 7.0),300 mM NaCI, 1 mM EDTA with 2.5 mM total lipoic acid 
(mixture of oxidized and reduced forms) and allowed to equilibrate for 3-4 hours. After 
equilibration, samples were removed and fluorescent spectra were determined at 25°C. 
Apparent redox midpoint potentials for the mutants were determined as described by 
Hanson et al (29). However, because oxidized lipoic acid absorbs near the 395nm 
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excitation maximum ofGFP, the intensity ratio of 505 urn fluorescence for excitation at 
the isobestic point (~425 urn) and 465 urn was used in the analysis. The midpoint 
potential (EO') oflipoic acid was assumed to be -0.290 V (42). All titrations were 
performed at least twice. 
Oxidation/reduction kinetics 
Reaction rates for reduction ofredox-sensitive GFPs by DTT and oxidation by 
oxidized cysteine (cysteine or CSSC) were determined by addition of a large excess of 
reagent (1 mM) and monitoring fluorescence over time. Solutions were degassed prior to 
use and experiments were conducted at 25°C, with ~1 ~M protein in 100 mM HEPES 
(pH 7.0), 300 mM NaCI and 1 mM EDTA. Prior to oxidation by CSSC, concentrated 
protein samples (~50 ~M) were incubated with ~1 mM DTT for one hour to reduce the 
protein. Removal ofthe remaining small amount DTT using a gel filtration spin column 
was found to have no significant effect on the rate ofoxidation. The pseudo first-order 
rate constant for the reactions were determined by fitting the reaction progress curves to a 
single-exponential function using KaleidaGraph (Synergy Software). 
Spectroscopy 
Fluorescence excitation/emission scans and kinetic traces were determined using 
a LS55 fluorescence spectrophotometer (PerkinElmer Life-sciences) or a FluoroMax-3 
fluorescence spectrophotometer (Jobin Yvon Inc.). Fluorescence quantum yields were 
determined by preparing protein samples so that absorbance at 400 urn equaled that of the 
....._-----------------------­
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standard 9-aminoacridine ("-max, abs = 400 nrn). Emission spectra were corrected for 
photomultiplier wavelength sensitivity and integrated as described previously (44, 54). 
Wild-type GFP and roGFP1 were utilized as controls. 
Crystal structure determination 
roGFP1-iR mutant (oxidized) was concentrated to ~25 mg/ml in 20mM HEPES 
(pH 7.9). Crystals grew in 1-2 days by hanging drop vapor diffusion against 0.1 M Tris 
(pH 8.5), 22-24% PEG 1550 and 0-0.06 M MgCh. Drops consisted of 1 ~l protein and 
1~1 well solution. Crystals of oxidized roGFP1-iR were transferred to a sitting drop 
(initially 10 ~l ofmother liquor) and artificial mother liquor containing 0.1 M Tris (pH 
8.0),30% PEG 1550,0.05 M MgCh and 20mM TCEP was added gradually over the 
course of two days (final drop volume was 50 ~l) to obtain crystals with reduced 
cysteines. 
roGFP1-iE (oxidized) was concentrated to ~25 mg/ml in 20mM HEPES (pH 7.9). 
Crystals grew in ~7 days by hanging drop vapor diffusion against 0.1 M Tris (pH 8.0), 
24% PEG 1550 and 0.04 M sodium acetate. Again, TCEP (20mM) was used to reduce 
crystals except the final condition was 0.1 M Tris (pH 8.0), 30% PEG 1550,0.05 M 
sodium acetate. 
X-ray diffraction data were collected from single frozen crystals for both mutants 
in both the oxidized and the reduced state at ALS beamline 5.0.1. Data sets were indexed 
and reduced using the HKL2000 suite (55). Molecular replacement solutions were found 
with MoIrep using the GFP S65T coordinate file (PDB code lEMA) as the search model. 
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ARP/wARP was used to rebuild the model (56). Refmac 5 (57) was used for further 
refinement after model building in Coot (58). ARP/wARP occasionally introduces water 
molecules into inappropriate density; therefore, waters were only kept or introduced if 
they were associated with reasonable electron density peaks and had appropriate 
proximity to hydrogen bonding partners. 
RESULTS 
Expression ofroGFP1 and roGFP2 mutants that involved insertion of single 
glycine residues adjacent to and on either side of Cys204led to soluble protein of the 
appropriate molecular weight, yet the protein was non-fluorescent; as a result this 
material was not characterized further. However, single glycine insertions adjacent to 
Cys147 were more successful and resulted in expression of fluorescent protein. Partial 
purification and characterization of a protein with an insertion N-terminal to Cys147 
(roGFP2-146NG) suggested that this molecule was responsive to changes in the ambient 
thiol disulfide equilibrium in vitro. However, the estimated midpoint potential ~ -285 
mV was close to that of the original roGFP2 and hence this variant was not further 
characterized. More promising behavior resulted from insertion of glycine C-terminal to 
Cys147 (roGFP2-147CG). Preliminary tests suggested that a disulfide with significantly 
decreased stability ~ -255 mV formed under oxidizing conditions. roGFP2-147CG has a 
single excitation peak at 490 nm and emission peak at 508 nm, the amplitude of which 
increases upon titration with reduced lipoic acid. 
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Random mutagenesis was then used to generate a library of variants with different 
excitation behaviors. Individual random mutants were expressed, purified and checked 
for aggregation behavior. Monomeric mutants were characterized further by adding DTT 
to the presumably O2 oxidized protein to determine the effect on the fluorescence 
excitation spectra. The majority of the mutants tested lacked the desired ratiometric 
behavior, the most common response being a general decrease in fluorescence intensity 
upon reduction. However, in a few cases ratiometric response was identified. As a result 
of these procedures, a promising family of variants was obtained (roGFP1­
147CXlH148S, also containing folding mutations, see Table 2-1), several members of 
which were further characterized. For the following discussion, we have adopted the 
shorthand notation roGFP1-iX, where X is the amino acid at insertion position 147a, to 
identify members of this family. 
Spectroscopic properties of roGFPl-iX 
The characterized members of the roGFP1-iX family have similar excitation and 
emission spectra, with excitation peaking at ~395nm (band A) and ~465nm (band B) and 
fluorescence emission peaking at ~505 nm. The relative amplitudes of the excitation 
peaks depend strongly on the presumed oxidation state of the 147-202 disulfide. In the 
oxidized state, excitation band A is favored over the band B; however, upon reduction, 
band B becomes dominant (Figure 2-1). The behavior is two-state with an isobestic point 
at ~ 425 nm. Fluorescence quantum yields for excitation at 400nm are somewhat lower 
than wild-type GFP or roGFP1 and range from 0.24 (roGFP1-iD) to 0.33 (roGFP1-iH), 
Table 2-1. roGFP-iX redox potential, kinetic and spectroscopic properties 
Xinsa EO! (mV) reduction rateb oxidation rateC cpd 'f/ Aem 400nmex Aiso 505nm em 
L -229±5 0.77 0.22 0.30 7.2 505 425
 
E -236±7 0.33 0.14 0.31 4.5 503 425
 
Q -239±6 0.33 0.21 0.31 4.1 505 425
 
H -238±4 0.47 0.22 0.33 3.1 505 425
 
R -237±5 0.27 0.22 0.24 2.9 502 425
 
S -240±3 0.48 0.24 0.31 2.4 505 425
 
D -246±1 0.23 0.18 0.24 2.8 502 425
 
roGFPl -287 0.18 0.33 0.64 6.5 508 425
 
a - mutations roGFPl (C48S/S147C/Q204C) + X insertionIH148S/F64L/F99S/Ml 53TNl 63A/I167T 
b - reduction by ImM DTT units of min-1 standard deviation less than ±0.05 (at least two trials) 
c - oxidation by ImM cystine units of min-1standard deviation less than ±0.05 (at least two trials) 
d - fluorescence quantum yield from excitation at 400 urn 
e - dynamic range is the maximum observed o-fold change in excitation peak ratio 
N 
w 
_._---_._._-------------------­
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Table 2-1 summarizes the spectral and biochemical properties of the variants. Dynamic 
.range (defined as the maximum observed ratio of excitation peak ratios) measurements 
indicate that the insertion mutants have fluorescence changes on the order of roGFP 1 
(6.5) with dynamic ranges spanning from 2.4 (roGFP1-iS) to 7.2 (roGFPl-iL). 
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Figure 2-1. Redox titration ofroGFP1-iE. (A) Fluorescence excitation spectra while 
monitoring emission intensity at 505 nm at the following redox potential values: -181 
(solid line), -224 (dashed and dotted line), -236 (dotted line), -247 (short dash line) and­
390 mV (long dashed line). (B) Fluorescence emission ratios were normalized to the 
highest and lowest intensities for each scan to produce a fraction reduced. The solid line 
represents the best fit to a theoretical two-state titration with a midpoint of -238mV. 
While wild-type GFP is insensitive to solution pH over the range of about 4-10 
(21, 59, 60); most mutations close in space to and including Hisl48 confer pH sensitivity 
and roGFPl-iX mutants are no exception. The excitation spectra of oxidized roGFP1-iE 
is quenched at low pH, and at pH 6.0 the fluorescence intensity is approximately half that 
at pH 7.0 (Figure 2). At high pH, beginning around pH 8.0, the spectra shifts from 
favoring the 395 nm peak to favoring the 465 peak. Similarly, in the reduced state at pH 
5.5, the fluorescence intensity is half that as at pH 7.0 and above pH 9.5 the 465 nm peak 
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becomes favored at the expense of the 395 run peak. The 465/395 ratio is essentially 
constant for both oxidized and reduced spectra between pH 6.0 and 8.0 indicating that 
this would be a useful range where pH artifacts are negligible (Figure 2-2). The pH 
dependence of roGFP l-iL was found to vary similarly to that of roGFP l-iE. 
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Figure 2-2. pH titrations of roGFP l-iE. (A) Oxidized spectra at various pHs. (B) 
Reduced spectra at various pHs. (C) Fluorescence excitation ratio versus pH. Circles are 
oxidized data and Xs are reduced data. Lines are drawn to guide the eye. 
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Redox equilibrium and reaction kinetics 
Redox midpoint potentials were determined from the equilibrium constant of the 
reaction between roGFPl-iX and lipoic acid (EO' assumed to be -290 mY, (42)), see 
Figure 1 for representative data. Redox midpoint potentials ranging from -229 mV 
(roGFPl-iL) to -246mV (roGFPl-iD) are summarized in Table 2-1. 
Pseudo-fIrst order rate constants for the reduction of the variants were determined 
by monitoring fluorescence over time after the addition of a large excess ofDTT (lmM) 
at pH 7.0, Figure 2-3. Rate constants for the insertion mutants ranged from kDTT 0.23 
min-I (roGFPl-iD) to kDTT 0.77 min-I (roGFPl-iL). All rate measurements had an error 
less than ±0.05 min-I determined by at least two experiments, see Table 2-1. The 
oxidation rates were determined under similar conditions using ImM cysteine (CSSC). 
Rate constants for the oxidation reactions varied from kcssc 0.14 min-I (roGFPl-iE) to 
kcssc 0.24 min-I(roGFPl-iS). Reversibility of the titration was verifIed by comparisons 
of spectra obtained before and after oxidation/reduction kinetic trials, normalized to the 
isobestic point to account for small changes in indicator concentration. By comparison, 
roGFPl was found to be reduced more slowly (kDTT 0.18 min-I, close to the previously 
reported value of 0.13 min-I (44)) than any of the roGFPl-iX. roGFPl also oxidized 
more rapidly (kcssc 0.33 min-I) than any roGFPl-iX. 
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Figure 2-3. Oxidation and reduction kinetics ofroGFP1-iE (triangles) and roGFP1 
(circles). The fraction reduced over time is shown after addition ofDTT (open symbols) 
or oxidized cysteine (solid symbols). Pseudo first-order rate constants were determined 
by fitting the rate curves (solid lines) to a single exponential. 
Crystal structure analysis of roGFPl-iR and roGFPl-iE 
Both variants crystallized in a P212121 lattice, which is approximately 
isomorphous to GFP-S65T (PDB ID code lEMA), and contains one molecule per 
asymmetric unit. Data collection and refinement statistics can be found in Table 2-2 for 
all atomic models described below. As expected, each model is very similar to that of 
wild-type or S65T GFP and consist of an 11 stranded beta barrel with an internal helix 
from which the chromophore forms. However, as detailed below, there are significant 
differences localized to the site of the amino acid insertion (position 147a) that are 
strongly influenced by the state of oxidation of the 147-204 disulfide. 
----------- -- --------
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Table 2-2. roGFP1-iX data collection and refinement statistics 
Crystal iE oxidized iE reduced iR oxidized iR reduced 
Data collection 
Total observations 180,776 125,308 190,447 136,444 
Unique reflections 52,564 35,231 54,553 41,093 
Cell dimensions (a, b, c) (A) 51.2,62.4,68.8 51.2, 62.3, 69.6 51.1,62.7,70.1 51.0,62.4,68.8 
Resolution (A) 50.0-1.31 50.0-1.50 50.0-1.31 50.0-1.40 
Highest resolution shell (A) 1.36-1.31 1.55-1.50 1.36-1.31 1.45-1.40 
Completenessa (%) 98.6 (92.4) 97.2 (95.1) 99.5 (99.8) 93.3 (93.6) 
Average 1/8 a 20.4 (1.9) 28.1 (2.1) 29.8 (9.8) 20.0 (1.6) 
Rmerl;e 
a,b 0.051 (0.429) 0.040 (0.472) 0.039 (0.098) 0.044 (0.449) 
Refinement 
Space group P2,2,2, P2,2,2, P2 j 212, P2,2,2, 
No. of molecules" 1 1 1 1 
No. of protein atomsC 1853 1790 1843 1821 
No. of solvent atoms' 268 242 303 228 
Resolution range (A) 50.0-1.31 50.0-1.50 50.0-1.31 50.0-1.40 
Crystallographic R -factord 0.164 0.188 0.152 0.185 
R-free 0.186 0.210 0.170 0.208 
Average B -factors (N) 
Protein atoms 14.0 17.9 9.8 14.6 
Solvent 25.9 29.1 20.2 24 
Root mean square deviations from ideality 
Bond lengths (A) 0.007 0.010 0.007 0.010 
Bond angles (degrees) 1.451 1.450 1.363 1.437 
a Values in parentheses indicate statistics for the highest resolution shell.
 
b R merge = L II-<1>1 / L <I>, where I is the observed intensity, and <I> is the average of intensities obtained
 
from multiple observations of symmetry-related reflections. 
C Per asymmetric unit. 
dR-factor = LIIF ai-IF ell / LIF 01, where Fa and Fe are observed and calculated structure amplitudes, respectively. 
Oxidized roGFPl-iR. The oxidized form of roGFP1-iR diffracted to better than 
1.31 Aresolution at the ALS beamline 5.0.1, with the data resolution being limited by 
detector geometry. The final model consists of residues 3-231 with none in the 
disallowed regions of the Ramachandran plot. The final model has an R-factor of 0.152 
and an R-free of 0.170 at 1.31 A. 
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Residues Asn146, Cys147, Arg147a, Ser148 and Cys204 are all clearly defined 
by electron density maps. For representative electron density, see Figure 2-4. Residues 
Cys147 and Cys204 form a disulfide that spans two adjacent segments of beta sheet and 
is in the pg-t (positive MS torsion angle with a "gauche-" X1n value of ~ -60° and "trans" 
xlC value of --±180° (61)) conformation (see Table 3). For comparison, the torsion angles 
describing the disulfides found in other redox sensitive GFPs are included in Table 2-3. 
As described in the study of disulfide conformations by Srinivasan et al. (61), there are 
relatively few disulfides in this conformation (2 of the 72 studied), the closest are 
immunoglobulin Fab (PDB ID code IFB4, H chain residues CyslOl and Cysl04) and 
human lysoszyme (PDB ID code lLZl, residues Cys77 and Cys95). Remarkably, the 
peptide bond between Cys147 and Arg147a is in the rare cis conformation (62). The side 
chain of Arg147a spans a gap between the strands containing the disulfide and forms 
hydrogen bonds with Ser202 and the backbone carbonyl ofPhe223. The hydroxyl of 
Ser148 forms a hydrogen bond to the chromophore hydroxyl group. The chromophore is 
slightly bent from planarity with a twist and tilt of 1.3 and 9.6, respectively (63). 
Table 2-3. Comparison of disulfide torsion angles 
1n 1c 2n 2c 3 Ca-CaA cp-cpA DSE*X X X X X 
roGFP2 average 
-67 -64 -100 -79 116 4.0 4.2 19.5 
roGFP1-R7 average -58 -58 -104 -78 105 4.0 4.1 
rxYFP 147202 average -58 -64 -99 -83 103 3.9 4.1 14.7 
roGFP1-iR -80 180 -150 45 86 4.9 3.8 11.7 
roGFP1-iE -59 -178 -157 46 68 4.6 3.5 8.0 
For Xangles, n refers to N-terminal cysteine and c for C-terminal cysteine 
*Disulfide strain energy kllmol 
15.5 
30 
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Figure 2-4. roGFPl-iR in oxidized and reduced states. (A) Stereo image of oxidized 
state with error weighted Fo-Fe omit map density at 30 in green. Red arrow denotes rare 
non-proline cis-peptide bond. (B) Stereo image of reduced state with error weighted F0­
Fe omit map density at 2.50 in green (C) Overlay of roGFPl-iR in the oxidized (black) 
and reduced (lavender) states. 
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Reduced roGFPl-iR. Reduced roGFP1-iR crystals diffracted well and data 
statistics were acceptable to 1.40 A. The final model consists of residues 2-231 with 
none in the disallowed regions of the Ramachandran plot. The final model has an R­
factor of 0.185 and an R-free of 0.208. The backbone of residues Asn146, Cys147, 
Arg147a and Ser148 have clear density, and while the side-chains are found in slightly 
weaker density, a satisfactory model could be constructed, see Figure 2-4. A large 
conformational change is observed for residues 146-147a relative to the oxidized state 
and the peptide bond between residues 147 and 147a is in the normal trans configuration 
(see later section for a more detailed comparison). Both the Cys147 and Cys204 side 
chains are disordered and are modeled in two conformations. Ser148 is hydrogen bonded 
to the chromophore, whereas Arg147a forms a salt bridge with Asp117 of a symmetry 
related molecule. The chromophore twist and tilt components are 0.7 and 11.2 
respectively (63). 
roGFPl-iE. Diffraction data for oxidized roGFP1-iE were collected to 1.31 A 
resolution with good statistics. The final model consists of residues 3-147 and 148-231 
with none in the disallowed regions of the Ramachandran plot and an R-factor and R-free 
of 0.164 and 0.186, respectively. Electron density is clear for all groups adjacent to the 
disulfide except for the inserted amino acid Glul47a. Although weak density was present 
for the main chain at position 147a, it was not sufficiently clear to permit modeling of a 
single conformation and thus this entire residue was omitted from the model, see Figure 
2-5. In contrast, Asn146, Cys147 and Ser148 could be satisfactorily modeled. The 
disulfide ofroGFPl-iE shares the same pg-t conformation as roGFPl-iR. 
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Figure 2-5. roGFPl-iE in the oxidized state. Stereo image with error weighted Fo-Fe 
omit map density at 30 in green. 
The 1.50 A model of reduced roGFPl-iE consist of residues 3-231, with non in 
the disallowed regions of the Ramachandran plot, and a R-factor and R-free of 0.188 and 
0.210, respectively. A 2Fo-Fe electron density map indicates weak density for the 
backbone atoms of Asn146 and side chain. There is weak Fo-Fe density for two 
conformations of the Glu147a Cy but not enough density to model the carboxyl groups. 
Additional density near (~2.0 A) the Sy of Cys204 in one conformation is present and is 
unlikely to indicate an oxidation product due to geometric considerations, however the 
density is likely to be a water molecule corresponding to the alternate conformation of 
Cys204. Cys147 is also observed in two conformations with weak Fo-Fe density. 
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Structural comparison of oxidized and reduced roGFPl-iX 
Comparisons of the oxidized and reduced states of the variants reveal surprising 
result. In each case oxidation/reduction induces a dramatic conformational change 
whereby the segment comprising residues 146, 147, 147a adopts entirely different 
conformations in the two states. Furthermore, it is clear from the roGFP1-iR variant that 
the peptide bond between 147-147a undergoes cis-trans isomerization during the open­
closed transition, with the cis configuration formed in the oxidized state. Interestingly, 
the most extreme motion of any atom in the loop 146-147a is exhibited by Sy ofCys147, 
which moves approximately 8 Abetween the two states (see Figure 2-4). 
The Asn146/Cys147/Xaa147a segment is anchored at one end by Tyr145, whose 
side chain is buried in the core of the protein, and at the other end by Ser148, which is 
pinned by backbone hydrogen bonds to the adjacent ~-sheet and a hydrogen bond to the 
chromophore. As judged from the refined thermal parameters (B-factors), the open 
(reduced disulfide) loop conformation is characterized by a higher degree of flexibility 
than observed for this same segment in the closed (disulfide) state. For oxidized roGFP1­
iR, the main chain B-factor average ofAsn146/Cys147/Arg147a atoms is 15.2 A2, which 
is larger than the average for the whole structure (residues 7-227) of 8.9 A2. Similarly, in 
the reduced state the B-factors of the loop are 22.6 A2 while the average is 12.9 A2. 
roGFP1-iE shows similar behavior with respect to the B-factors with the oxidized and 
reduced loops having average B-factors of 20.4 A2 and 34.1 A2 and overall averages of 
12.9 A2 and 17.0 A2 respectively. In any case, the open-closed conformational change is 
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well described by a two state model, in which only the atoms of the segment l46-l47a 
are seen to move. 
In contrast to the segment 146-147a, the peptide containing Cys204 is essentially 
umesponsive to changes in the oxidation state of Cys204. This peptide is locked in place 
by virtue of the regular backbone hydrogen bonds to the neighboring ~-strand (residues 
221 - 225) and by side chains buried within the protein. However, the Ca-C~ torsion 
angle of Cys204 is variable, with the Cys204 S')' occupying at least two conformations 
(Figure 2-4). 
X-ray diffraction data were collected with short exposures to minimize x-ray 
induced damage. Nevertheless, the weaker density for Cys147 in the reduced states of 
roGFP1-iR and roGFP1-iE may be a result of x-ray damage, it may also result from the 
flexibility of the loop. Cys204 in the roGFP1-iR structure appears to have no oxidation 
artifacts associated and little negative density in the Fo-Fc map as modeled indicating 
minor radiation damage. 
A feature of oxidized roGFP1-iR is that the hydrophobic portion of the Arg147a 
side chain is extended and lies adjacent to the disulfide bridge, partially shielding this 
group from solvent. Moreover, the Arg147a conformation is secured by a hydrogen bond 
between Ne ofthe guanidinium group and 0')' ofSer202. We think that this interaction is 
important and helps to rationalize the anomalous ordering of midpoint potentials within 
the roGFP1-iX series (see Discussion). In the reduced state, this interaction is lost, and 
the Arg147a side chain makes polar interactions with a neighboring molecule in the 
crystal. For the Glu147a variant, such a stabilizing interaction is either not possible or 
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energetically unfavorable, as the glutamate side chain is not ordered in either the oxidized 
or reduced form. 
Comparison of roGFP1-iR and roGFP2 
Crystal structures are available for roGFP2, which differs from roGFPl by only a 
single methyl group (resulting from the Ser65 ----+Thr substitution). roGFP2 thus serves as 
a good model for roGFPl, which is the parent for the roGFPl-iX variants described 
herein. Both oxidized and reduced forms ofroGFP2 were reported by Hanson et al. (29). 
Comparing the two roGFP2 structures, oxidation/reduction results in only very small 
changes in the positions of the cysteine side chains, thus they are strongly localized by 
the protein fold. Furthermore, according to a statistical database (61), compiled from 
available protein structures and calculation of the disulfide energy strain (DSE) (64) 
(Table 2-3), the geometry of the disulfide linkage in oxidized roGFP2 is highly strained, 
which is assumed to be a consequence of rigidity in the p-barrel fold of the protein. In 
strong contrast, the largest motion observed upon oxidation/reduction ofroGFPl-iX 
variants is rearrangement of Cys204, which moves by up to 8 Asuggesting that a great 
deal of flexibility is imparted by the insertion. 
Furthermore, the protein backbone accommodates the insertion between residues 
147 and 148 in different ways dependent upon the oxidation state (Figure 2-4). Two 
positions, Tyr145 and Serl48, pin the ends of the segment containing the insertion. 
Tyrl45 is fixed as part of the hydrophobic core of the protein, whereas Serl48 is oriented 
by hydrogen bonds in the regular p-sheet around that position. However, the intervening 
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peptide conformation varies greatly depending upon the oxidation state of the 
thiol/disulfide. In the oxidized state, formation of the disulfide forces Arg147a to bulge 
out of the barrel (Figure 2-6). In the reduced state, Arg147a appears to be in a position 
similar to that of the Cys147 in roGFPl and instead, Asn146 is bulged out. Hence, the 
actual dislocation resulting from the insertion translocates in response to the side chain 
oxidation state, much as observed for insertions within the backbone ofhelical regions in 
T4lysozyme (65). For both wild-type GFP and roGFP2 in the reduced state the 
Asn146/Ser147/His148 strand has B-factors that are comparable with surrounding 
residues, which is in contrast to roGFPl-iR where the B-factors are much larger than 
average for this loop. This suggests that in addition to two-state conformational 
flexibility (i.e. static disorder), the insertion also confers to the backbone greater 
microscopic heterogeneity (dynamic disorder). 
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A 
B 
Figure 2-6. roGFP1-iR and roGFP2 comparison (A) Overlay of oxidized roGFP2 (green) 
and roGFP1-iR (black). (B) Overlay ofreduced roGFP2 (green) and roGFP1-iR 
(lavender). 
DISCUSSION 
Two-state indicators that depend upon chemical equilibrium are useful for 
quantitative analysis over a rather narrow range, centered upon the conditions where the 
equilibrium constant for interconversion of the two indicator species is one. Inevitable 
measurement errors introduce further restrictions on this range. roGFPs 1-6 exhibit 
midpoint potentials that range from -272 mV (roGFP2) to -299 mV (roGFP3). In 
practice, roGFPs are most useful for measuring the thiolldisulfide equilibrium within ~35 
mV of the indicator midpoint, corresponding to ~ 10-90% oxidized. roGFP 1 (midpoint ~ 
-290 mV), for example, is most useful for quantitative measurements within a range of~ 
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-255 to -325 mV at pH 7.0. However a much wider range is found within cells from 
around -360 mV for the mitochondria (29, 33) to -180mV for the ER (35). 
Partly in effort to extend this range limitation, several groups have introduced 
surface positive charges such as arginine and lysine residues into the vicinity of the 
reactive disulfide. In theory, these modifications favor formation of the cysteine thiolate, 
which in turn destabilizes the disulfide. This has two important consequences, one of 
which is to significantly accelerate the rate constants for oxidation and reduction (by 
increasing the concentration of the reactive thiolate), while the second is to shift the 
midpoint potential toward less negative values. Dooley et al. (32), Cannon and 
Remington (44) and Hansen et al. (45) successfully applied this approach. 
Of the roGFPI-Rn variants described by Cannon and Remington (44), roGFP1­
R12 and -14 (each with three basic substitutions) exhibit the least negative midpoint 
potentials of -265 mV and -263 mY, respectively. Introduction of three basic groups thus 
leads to rather modest shifts of 22-24 mY, compared to roGFPl at about -287 mY. 
Despite the apparent success of this approach and the general agreement with 
theory, the unusual stability of the disulfide in roGFP1I2 is puzzling because the high 
resolution crystallographic studies of roGFP2 revealed it to be geometrically quite 
strained (29). Given that our goal is to achieve more dramatic shifts in the midpoint 
potential, a more invasive approach to destabilize the disulfide linkage is required. To 
this end, we inserted single amino acid residues within the polypeptide backbone, 
adjacent to the reactive disulfides. A further requirement is that the indicator response be 
ratiometric; in this case, the response should entail a shift in equilibrium between two 
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forms excited at ~ 400 or ~ 475 run. Initial experiments using glycine insertions 
produced soluble but non-fluorescent protein (for insertion around Cys204) or indicators 
that were not ratiometric (insertion around Cys147). However, for one promising mutant, 
ratiometric behavior was restored utilizing random mutagenesis at certain selected sites. 
This effort produced a family of redox-sensitive fluorescent proteins termed roGFP1-iX, 
where the distinguishing feature is the identity "X" of the amino acid inserted at position 
147a, adjacent to Cys147. 
As shown in Table 2-1, these variants have midpoint potentials in the range of~­
229 to ~ -246 mY. Compared to the parent roGFP1, this corresponds to shifts of~ 50-60 
mV toward less negative midpoint potentials, indicating that the apparent equilibrium 
constant for disulfide formation in roGFP-iX is reduced by approximately an order of 
magnitude. All the variants have significantly increased rates of reduction by DDT over 
that of the parent roGFP1, however the rate of oxidation by cystine (CSSC) is similar for 
all variants. Closer inspection ofTable 2-1 reveals several interesting and 
counterintuitive results. Consider, for example, the variants roGFP-iL, roGFP-iR and 
roGFP-iE which have leucine, arginine and glutamate at position 147a, respectively. 
From the discussion above, it is expected that the positive charge on the arginine side 
chain would destabilize the disulfide compared to leucine or glutamate at this position, 
but the reverse is true. To rationalize these results, we compared the crystal structures of 
roGFP-iR and roGFP-iE in both the oxidized and reduced states. In the following 
section, we attempt to explain the apparent reduction in disulfide stability in terms of 
geometric, electrostatic and entropic contributions. 
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Geometric strain 
Comparison of the 147/204 disulfide geometry (Table 3) with the statistical 
database compiled by Srinivasan et al. (61) suggests that the disulfide linkage is only 
slightly atypical, for example, the disulfide X2 values of~ 1800 are infrequently observed. 
Thus, strain in the disulfide linkage itself is not likely to be a significant factor accounting 
for the reduced thermodynamic stability compared to roGFP1 or 2. Indeed, on a 
geometrical basis alone, the disulfide in roGFP 1-iR should be thermodynamically more 
stable that that seen in roGFP2. However, geometric strain in this system is apparent, 
which is illustrated by the presence of the rare and unfavorable cis-peptide bond between 
Cys147 and Arg147a (see Figure 2-4). Upon reduction of the disulfide, the cis peptide 
bond isomerizes to the more relaxed trans form. We conclude that trans to cis peptide 
isomerization is required in order to form an energetically favorable disulfide linkage, 
and that this component of the overall energetic status substantially reduces the apparent 
equilibrium constant for disulfide formation. The role of non-proline cis-trans peptide 
isomerizations in the active center of a protein has been demonstrated before in 
concanavalin A, suggesting these isomerizations are not completely novel (66). 
Electrostatic effects 
In theory, placement of a positive charge adjacent to a disulfide should decrease 
thermodynamic stability due to stabilization of the cysteine thiolate. This has been 
experimentally verified by several groups (41, 44, 67, 68), even to the level of good 
quantitative agreement with nonlinear Poisson-Boltzmann theory [Cannon & Remington 
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(44)]. However, comparing the midpoint potentials ofroGFP1-iR and roGFP1-iE or 
roGFP1-iL (Table 2-1), the variant with the positively charged arginine side chain has the 
most stable disulfide. On the basis of the crystal structures, we suggest that this ordering 
is due to a specific interaction found only in the oxidized state ofroGFP1-iR, where the 
guanidinium group forms a hydrogen bond to Ser202 Oy. In comparison, the Glu147a 
side chain is disordered in either state ofroGFP1-iE. This specific interaction, 
preferentially stabilizing only the oxidized state, is proposed to offset the generalized 
electrostatic effects. The large loop movement towards the open state also removes the 
l47a side chain from the immediate vicinity ofCys204, reducing electrostatic influences 
at this reactive center. 
Entropic effects 
The solution response of roGFP-iX indicators to redox titration is accurately 
modeled by a theoretical curve assuming two states, open and closed, in chemical 
equilibrium Figure 2-1. However, the crystallographic results indicate that the open form 
ofloop l46-l47a has high flexibility as the B-factors are higher than average. In the 
closed state ofroGFP-iR, this loop, including the side chain of Arg147a, is well ordered. 
This suggests that entropic considerations would favor the open, reduced state due to the 
increased number of degrees offreedom. Nevertheless, a two-state structural model that 
includes vibrational parameters is an adequate model for the transition, so the effect 
cannot be expected to result in a large reduction in the thermodynamic stability of the 
disulfide. The situation is less pronounced in the roGFP-iE variant, as both the main and 
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side chain of Glu147a are to some extent disordered in either the reduced or oxidized 
states, however it is still true that main chain vibrational parameters are relatively higher 
in the open confonnation than in the closed. 
On the other hand, the large confonnational change of the 147 loop, with a 
consequently large physical separation between the reactive species in the reduced state, 
can be rationalized in tenns of a low effective concentration of the reactive species. 
Alternatively, there are undoubtedly many loop confonnations on the reaction pathway 
that reduces the probability of disulfide fonnation. This is in contrast to roGFPl, in 
which the reduced cysteines are held in close proximity by the protein backbone and thus 
only minor rearrangements are required for disulfide fonnation. 
While it is difficult to estimate the magnitude of the loop entropy contribution to 
the thennodynamic stability of the disulfide, the effect is unlikely to be negligible. In 
concert with the geometric strain argument advanced previously, the two contributions 
are consistent with the observed reduction in disulfide stability. If correct, this argument 
suggests that larger insertions near the 147 position, possibly even containing the reactive 
cysteine, into the backbone of roGFPs could result in probes suitable for use in even more 
oxidizing environments. GFP is known to accommodate the insertion of entire proteins, 
such as calmodulin (26), in the vicinity of residue 146, so further exploration of our 
"insertion approach" has a high probability of success. 
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Suitability of roGFP-iX probes for use in vivo 
As described previously the range of activity of the redox indicators is around ±35 
mV from the midpoint potential, and for the most oxidizing indicator, roGFPl-iL, the 
range would be from -265 to -195 mY. Assuming the midpoint potential of the ER is­
180 mV as reported from isolation of glutathione levels, roGFPl-iL falls short of being 
able to determine the redox potential in that cellular environment. There are 
discrepancies in the reported values of the cytosolic redox potential between the methods 
of glutathione isolation (-232 mV (35)) and use of fluorescent redox sensors (-320 mV 
(32)), and as such the ER could be more reducing than previously indicated. What is 
known is that the ERredox potential is greater than -255 mV based on use ofroGFPl in 
that environment (36). The pH of the ER and Golgi have been reported to be 7.4 and 6.2 
(69) which is in the range of function ofroGFPl-iL or roGFPl-iE suggesting they should 
work fine in these environments. It is recommended based on the lack of intermolecular 
disulfide formation, spectral properties and highest redox potentials that roGFP l-iE and 
especially roGFPl-iL be used for in vivo experimentation. 
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CHAPTER III 
ATOMIC RESOLUTION STRUCTURES OF ESCHERICHIA COLI AND
 
BACILLUSANTHRACIS MALATE SYTHASE A: COMPARISON WITH
 
ISOFORM G AND IMPLICATIONS FOR STRUCTURE BASED DRUG DESIGN
 
Experimental data presented in this chapter are my own with some data collection 
done by Andrew Olson. I prepared the original manuscript. Jim Remington provided 
direction, support and edited the manuscript. 
SUMMARY 
Enzymes of the glyoxylate shunt are important for the virulence of pathogenic 
organisms such as Mycobacterium tuberculosis and Candida albicans. Two isoforms 
have been identified for malate synthase, the second enzyme in the pathway. Isoform A, 
found in fungi and plants, comprises ~530 residues, whereas isoform G, found only in 
bacteria, is larger by ~200 residues. Crystal structures of malate synthase isoform G from 
Escherichia coli and Mycobacterium tuberculosis were previously determined at 
moderate resolution. Here we describe crystal structures of Escherichia coli malate 
synthase A (MSA) in the apo form (1.04 Aresolution) and in complex with acetyl­
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coenzyme A and a competitive inhibitor, possibly pyruvate or oxalate (l.40 A 
resolution). In addition, a crystal structure for Bacillus anthracis MSA at 1.70 A 
resolution is reported. The increase in size between isoforms A and G can be attributed 
primarily to an inserted a/~ domain of unknown function. Upon binding of inhibitor or 
substrate, several active site loops in MSA undergo large conformational changes. 
However, in the substrate bound form, the active sites ofisoforms A and G from 
Escherichia coli are nearly identical. Considering that inhibitors bind with very similar 
affinities to both isoforms, MSA is as an outstanding platform for high-resolution 
structural studies and drug design efforts. 
INTRODUCTION 
Malate synthase (MS) and isocitrate lyase make up the glyoxylate shunt (11), 
which ultimately converts isocitrate to malate. The actions of these enzymes bypass two 
steps of the citric acid cycle that evolve CO2, permitting bacteria, fungi and plants to 
utilize C2 carbon sources such as acetate and fatty acids for net biosynthesis. Enzymes of 
the glyoxylate shunt have been implicated for the virulence and persistence of many 
different pathogens, especially Mycobacterium tuberculosis (mTB) (70-72) and Candida 
albicans (73-75). As mammals do not have genes encoding either glyoxylate shunt 
enzyme, they have become attractive targets for drug design (76). 
Two distinct isoforms ofMS, A (MSA) and G (MSG) (77) have been identified. 
Members of the isoform G family share >50% identity and are found only in bacteria 
(78). Likewise, MSA isoforms share high identity but are found in fungi and plants as 
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well as bacteria. The eukaryotic MSAs form homomultimers, which distinguishes them 
from prokaryotic MSAs (79). Both isoforms are represented in pathogenic organisms, for 
example, mTB utilizes a G isoform, whereas Candida albicans utilizes isoform A. 
Escherichia coli is thus far unique in that it has genes for both MSA and MSG, 
encoded by the genes aceB and glcB respectively (80). The proteins are differentially 
expressed in E. coli with isoform A expression being regulated by fatty acids and acetate 
while isoform G expression is regulated by glycolate (81). E. coli MSA (ecMSA) 
comprises 533 amino acids whereas E. coli MSG (ecMSG) comprises 723 amino acids. 
The two isoforms are very distantly related. Sequence comparisons suggest that the 
larger size of the G isoform can be attributed to the presence of one or more insertions 
(13, 78, 80), while the conserved segments of the amino acid sequence show only ~ 18% 
identity. Crystal structures of malate synthase G from E. coli (13, 14) and from mTB (78, 
82) have been determined, but unfortunately the diffraction resolution is modest, which 
limits structure-based drug design efforts (83). 
Structural studies of mTB MSG and ecMSG reveal four structural domains (13, 
14, 18, 78, 82, 84). A a8/~8 (TIM) barrel is centrally located and contains the active site. 
It is buttressed on one side by an N-terminal a-helical clasp and on the other by an a/~­
domain consisting of two insertions into the barrel. The C-terminal segment, which 
comprises several a-helices, caps the active site. As of yet, no function has been 
attributed to the a/~-domain. Sequence alignments proposed by a few groups disagree 
with respect to which domains are missing from the structure of MSA. Alignments from 
Smith (78) and Howard (13) suggest the N-terminal clasp domain is missing whereas the 
--------------------
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alignment of Molina (80) predicts the absence of the a/~-domain, however both 
alignments agree that the C-tenninal cap and the TIM barrel are well conserved. 
In the second step of the glyoxylate shunt pathway, the condensation and 
subsequent hydrolysis of glyoxylate and acetyl-CoA is perfonned by MS to produce 
malate and CoA. The modes of substrate binding are known in some detail from 
crystallographic and NMR structural studies (13, 14, 18, 78, 82, 84, 85) and a catalytic 
mechanism has been proposed. Briefly, bound glyoxylate is activated towards 
nucleophilic attack by salt bridges to an essential Mg2+ ion and by hydrogen bonds to the 
protein backbone and a conserved arginine. The acetyl-CoA tenninal methyl group is 
deprotonated by the catalytic aspartate residue. The proposed enolate intermediate is 
stabilized by interaction with the catalytically essential arginine. 
The binding site for the substrate glyoxylate is deep within the protein, connected 
by a channel to the solvent-exposed acetyl-CoA binding site. Prior to the structural 
studies, the results of small angle x-ray scattering experiments suggested "opening" or 
separation of domains so that the active site could sequester substrates from the solvent 
(15). Substrate-induced confonnational changes were also consistent with circular 
dichroism data on MS isolated from maise and yeast (16, 17). In contrast, data from 
subsequent NMR studies of apo ecMSG were inconsistent with domain motions, but did 
suggest disorder in a loop (Thr451-Asp455) that could control access to the active site 
(18). 
We report here crystal structures of ecMSA and Bacillus anthracis MSA 
(baMSA). These structures reveal that the conserved portions of MSA and MSG are very 
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similar and that the difference in size is due to the a/~-domain appended to the G isoform. 
Comparisons of E. coli MSA apo and ternary complex structures reveal significant loop 
movements, which we suggest are necessary for substrate binding and product release. 
Active site comparisons of the two substrate-bound isoforms, combined with kinetic 
studies, suggest that either isoform could be used as a basis for drug discovery. 
METHODS AND MATERIALS 
Cloning, mutagenesis, overexpression and purification 
The gene for ecMSA was amplified from genomic DNA using primers containing 
restriction endonuclease cut sites. The fragments after digestion were cloned into a 
modified pBAD expression vector containing a TEV protease site in place of the 
enterokinase cleavage site. The ecMSA C438S mutant was prepared using the 
QuickChange Site-Directed Mutagenesis Kit (Stratagene) and the presence of the 
mutation was verified by DNA sequencing. A synthetic gene coding for the Bacillus 
anthracis MSA gene was produced by Blue Heron Biotechnology and sub-cloned 
similarly to the ecMSA gene. The ecMSG C617S mutant was prepared as described 
previously (14). 
The pBAD vector containing ecMSA or baMSA was transformed into E. coli 
TaPIa cells. These cells were cultured overnight in 100 mL Luria-Bertani media 
supplemented with ampicillin (lOa llg/mL). This culture was used to inoculate 4 L of 
media in a fermenter at 37°. Once the culture reached an A600 of 0.6-0.8, 2 g arabinose 
was added to start overexpression. After 4-hours the culture was harvested by 
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centrifugation, disrupted by sonication with the addition of lysosyme and DNAse, 
followed by centrifugation to remove insoluble material. 
Purification was performed using a Ni-NTA column. The His-tag was removed 
exclusion or anion exchange chromatography. The protein was dialyzed into 50 mM Tris 
using 0.15 mg TEV protease per 20 mg purified protein and checked for cleavage using 
MALDI/TOF MS. After complete cleavage the protein was further purified using size 
pH 8.0, 20 mM KCl, 5 mM MgC12, 1 mM TCEP, 0.1 mM EDTA then quantified using 
+
+
1 lthe calculated 828081.8 mM- based the method of Gill and von Hippel (86), and cm- on 
concentrated to approximately 20 mg/mL prior to crystallization. 
Crystallization, derivatization and diffraction data collection 
+
Large, diffraction quality crystals of ecMSA were readily obtained from many 
conditions by using the hanging drop vapor diffusion technique. The optimized condition 
for apo ecMSA was 0.1 M Tris pH 7.5,0.2 M calcium acetate, 22% PEG 8K (1:1, 
protein: reservoir solution, 2 /-!L drops). A heavy atom derivative was prepared by 
soaking a crystal for one hour in HgCh saturated mother liquor (87). Crystals were flash 
frozen and data were collected on a Rigaku rotating anode generator with a Raxis 4 
detector. To produce the Mg2
mother liquor where Ca2 was replaced by Mg2
bound ecMSA structure, crystals were placed in artificial 
and stored for 7 days before data 
collection data at the Advanced Light Source (Berkley, CA), beam line 5.0.2 using the 
ADSC-Q315 detector at a wavelength of 0.90 Aand temperature of lOOK. To obtain the 
ecMSA acetyl-CoAiinhibitor ternary complex, protein was mixed with 0.1 M acetyl-CoA 
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and 0.2 M pyruvate, which was then again subjected to crystallization trials. The ternary 
complex crystallized from 0.1 M PIPES pH 6.5, 0.1 M ammonium sulfate, 27% PEG 8K. 
Crystals of baMSA grew from 0.2 M sodium citrate, 0.1 M Tris pH 8.0, 30% PEG 1550 
from which two crystal forms are found, small needle clusters and large plates. Large 
plates of baMSA were used for data collection. It was later found that inclusion of 30-70 
mM NiCh in the crystallization buffer encouraged formation of the plates over the 
needles. Synchrotron radiation at ALS beamline 5.0.2 (wavelength 1.00 A) was used for 
data collection on the ecMSA inhibitor/acetyl-CoA complex and for the baMSA crystal. 
Data reduction and structure determination 
The home source diffraction data for apo ecMSA were processed and scaled with 
the HKL suite (55). Initial phases were obtained and modified with SHELXC/DIE using 
the SIRAS method (88,89). Five heavy atom sites were found. ARP/wARP was then 
used to build the model into the experimentally phased electron density map (56). Five 
hundred ofthe five hundred thirty three amino acids were automatically built. The 
phases from ARP/wARP were extended to 1.68 A using REFMAC 5 (57). Additional 
amino acids were built using COOT (58). Water molecules were placed using COOT 
with the combined criteria of a peak of greater than 2.5 cr in the (Fa-Fe) difference map, or 
1.0 cr in the (2Fo-Fc ) map and reasonable intermolecular interactions. Synchrotron data 
were processed using the HKL2000 suite (55). Molecular replacement, using MOLREP 
(90), was performed to solve the structures of the acetyl-CoA/inhibitor ecMSA and 
baMSA structures using the apo ecMSA structure as a starting point. ARP/wARP was 
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also used to rebuild the models of the acetyl-CoA/inhibitor bound ecMSA and baMSA 
(56). The magnesium bound ecMSA, acetyl-CoA/inhibitor bound ecMSA, and baMSA 
structures were all refined using REFMAC 5 (57). 
Enzyme activity assay 
The reaction of acetyl-CoA and glyoxylate catalyzed by ecMSA and baMSA was 
quantified by measuring the decrease in absorbance at 232 nm due to cleavage of the 
thioester bond of acetyl-CoA as described previously (14, 79). The reaction conditions 
were 0.2 mM acetyl-CoA, 0.5 mM glyoxylate, 50 mM Tris pH 8.0 and 10 mM MgClz. 
The reaction was initiated by the addition of enzyme solution. Kinetic parameters for 
substrates were determined using the above conditions with varying substrate 
concentrations. Least squares fits for kinetic parameters were obtained using the program 
Enzfitter (Biosoft). Inhibition constants for parabanic acid and 4-amido-2,3,4­
pyrrolidenetrion (which absorb in the vicinity of232 nm where the thioester linkage of 
acetyl CoA absorbs), were determined using an assay that monitors the appearance of 
free CoA via its reaction with 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) and the 
concomitant rise in absorbance at 412 nm (91). However, there was a concern that 
Cys438, a conserved residue in the active site of MS, might react with Dll"l"B to block 
catalysis, so Cys438 was mutated to serine prior to kinetic analyses. The assay 
conditions were similar to above with a 1 mM concentration ofDTNB. 
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RESULTS 
We successfully cloned ecMSA from genomic DNA. Since genomic DNA was 
not available for baMSA, the gene was synthesized commercially. Overexpression 
yielded protein for both ecMSA and baMSA. Kinetic and inhibition constants were 
obtained for both ecMSA and baMSA allowing comparison with ecMSG. Both ecMSA 
and baMSA crystallized readily, but ecMSA produced crystals ofmuch higher diffraction 
quality. 
Kinetics and inhibition of malate synthase 
The kinetic properties of ecMSA and baMSA are very similar and in addition are 
similar to those of ecMSG as shown in Table 3-1. ecMSA Cys438, corresponding to 
Cys617 in ecMSG, was mutated to Ser similarly to as performed by Anstrom et al. (14). 
Inhibition by the glyoxylate competitive inhibitors pyruvate, parabanic acid and 4-amido­
2,3,4-pyrrolidenetrione were very similar between the isoforms, indicating that either 
isoform should be useful for drug discovery. The binding of pyruvate and parabanic acid 
are relatively weak with low to sub millimolar inhibition constants, whereas 4-amido­
2,3,4-pyrrolidenetrione binds better with mid-micromolar inhibition constants and could 
be improved. Parabanic acid evidently undergoes base and/or enzyme catalyzed 
hydrolysis under the conditions used in the assay, however, the reaction is slow enough 
that inhibition constants could be obtained. While the affinity of parabanic acid for the 
enzyme is modest, in theory it is readily functionalized, therefore parabanic acid could be 
an excellent lead compound for drug discovery. 
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Table 3-1. Kinetic and inhibition constants for malate synthases 
Enzyme ecMSA WT ecMSA C438S ecMSG WTb ecMSG C167Sb baMSA 
specific activity" 2500±100 l850±50 3400±35 3000±60 2300±20 
% of wild type activity 100 74 100 88 100 
Km glyoxylate (11M) 55±7 58±7 2l±2 50±4 85±2 
Km acetyl-CoA (11M) 22±3 56±2 9.0±1.1 46±3 23±3 
Ki pyruvate (mM) 0.600±0.008 1.0±0.2 1.00±0.09 0.750±0.025 
Ki parabanic acid (11M) 370±50 550±60 
Ki pyrrolidinetrione (11M) 40±7 113±12 
(a) units of mol malate/min.lmol protein 
(b) values taken from Anstrom et al. 2003, except data regarding parabanic acid and pyrrolidinetrione 
ecMSA apo form structure 
E. coli MSA crystallized readily from calcium acetate/PEG 8K in space group P21 
with a single monomer per asymmetric unit and unit cell dimensions of a = 52.0 A, b = 
74.1 A, c = 71.9 Awith P= 97.8°. These crystals diffracted well and data were collected 
using the home source to 1.68 Aresolution with excellent statistics (see Table 3-2). The 
structure was solved using the SIRAS method using a HgCh heavy atom derivative data 
set which diffracted to 1.80 A. The final model has a crystallographic R factor of 0.172 
(Rfree = 0.200). It consists of residues 5-533 with two Ca2+ ions and one molecule each of 
glycerol and acetate. Only amino acid, Glul19, is found in the generously allowed 
region of the Ramachandran diagram, with none in disallowed regions. 
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Table 3-2. Malate synthase A data collection and refinement statistics 
Crystal ec native ec derivative ec Mg++ soaked ec inhibitor baMSA 
Data collection 
Total observations 214,408 186,790 766,437 785,650 138,489 
Unique reflections 59,002 48,087 195,926 229,489 43,852 
Cell dimensions a (A) 52.0 51.9 52.1 75.2 97.8 
b (A) 74.1 73.7 73.9 71.5 52.0 
c (A) 71.9 71.9 71.7 103.3 89.1 
u=y=90° P=97.8° P=97.7 P=98.0 P=90.1 P=98.9 
Resolution (A) 50-1.68 50-1.80 30-1.04 30-1.40 50-1.70 
Highest resolution shell (A) 1.74-1.68 1.86-1.80 1.08-1.04 1.45-1040 1.76-1.70 
CompletenessQ (%) 96.9 97.6 89.5 97.1 89.9 
(97.8) (94.6) (50.9) (94.7) (62.3) 
Average II a Q 26.1 19.8 12.2 25.1 19.1 
(2.6) (2.3) (2.15) (1.8) (2.4) 
R merge 
Q,b 0.055 0.081 0.078 0.057 0.057 
(0.427) (0.454) (0.399) (0.551) (0.280) 
Refinement 
Space group P2] P2 1 P21 P2] C2 
No. ofmolecule{ 1 1 I 2 I 
No. ofprotein atomsC 4236 4341 8504 4010 
No. of solvent atomsC 516 641 1159 180 
Resolution range (A) 30-1.68 30-1.04 30-1.40 30-1.70 
Crystallographic R -factol 0.177 0.153 0.173 0.201 
R -free (reflections) 0.208 0.166 0.200 0.245 
Average B -factors (N) 
Protein atoms (main chain) 14.3 10.2 19.4 24.6 
Solvent 21.5 19.0 29.5 30.1 
Root mean square deviations 
Bond lengths (A) 0.013 0.006 0.009 0.019 
Bond angles(O) 1.36 1.07 1.21 1.78 
a Values in parentheses indicate statistics for the highest resolution shell. 
b R merge = L 1<1>/ L <I>, where I is observed intensity, <I> is average intensities from multiple observations of 
symmetry-related reflections. 
C Per asymmetric unit. 
dR-factor = LIIF ol-iF cilILIF 01, where F 0 and Fe are the observed and calculated structure amplitudes, respectively. 
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ecMSA ternary complex structure 
Solutions containing ecMSA, acetyl-CoA and pyruvate in ammonium 
sulfate/PEG 4K yielded ternary complex crystals in space group P21 with two protomers 
per asymmetric unit. The unit cell dimensions are a = 75.2 A, b = 71.5 A, c = 103.3 A 
with P= 90.1 0 These co-crystals diffracted well and data with good statistics were • 
collected to lAO A(Table 2). The final model was solved by molecular replacement 
using the apo-form model, and has a final crystallographic R factor of 0.173 (Rfree = 
0.200). The final ternary complex model consists of residues 9-533, one Mg2 + ion, either 
pyruvate or oxalate and one molecule of acetyl-CoA for each protein chain.1159 water 
molecules were placed. Alignment of the A and B molecules in the asymmetric unit 
shows them to be essentially identical with a rmsd of 0.05 A. A single residue, Glul19 in 
both monomers, was in a generously allowed region of the Ramachandran diagram, and 
no residues are in the disallowed regions. However, the unusual conformation of Glul19 
is supported by clear electron density. 
Overall structure 
E. coli malate synthase A is fashioned from an N-terminal a-helical clasp 
(Domain I, residues 5-60) which interfaces with a a8/p8 TIM barrel (Domain II, residues 
92-383) and a C-terminal a-helical plug (Domain III, residues 414-533), as shown in 
Figure 3-1, panel A. Domains I and II are linked by a loop region (resides 61-91) 
containing a single a-helix of approximately the diameter of the protein, covering the 
"bottom" of the TIM barrel. Residues 384-413 form a similar helical region that extends 
the diameter of the protein to connect domains II and III. 
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Figure 3-1. Structure of ecMSA with acetyl-CoA and inhibitor bound. Panel A. Stereo­
view of overall structure. TIM barrel (green), C-tenninal plug (red), N-tenninal clasp 
(blue). CoA fragment and inhibitor shown in lavender ball-and-stick with magnesium as 
orange sphere. Black ball-and-stick residues from left-to-right are R276, W277, M330, 
P369 and M102. Panel B. Stereo-view of active site inhibitor with omit Fo-Fc density 
shown at 30- for the inhibitor, magnesitum and a few residues. Black dashes represent 
hydrogen bonds with the red dashes showing the "bad contact" with pyruvate or 2.7 A 
hydrogen bond to oxalate which is modeled. Based on comparisons with MSG the blue 
dashes represent the hypothetical interaction ofAsp447 and the tenninal methyl group of 
acetyl-CoA. Panel C. Stereo-view of the CoA binding site with omit Fo-Fc density 
shown at 20- for CoA and Cys438. There is some density for the panthothenic acid 
moiety but it is too broken to accurately model. The waters at the top of the panel 
interacting with D447 represent the hypothetical location of the tenninal acetyl group. 
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Active site of apo ecMSA 
The active site of apo ecMSA has two channels leading to the solvent, in an 
approximately perpendicular orientation. Residues 439-446 in the C-terminal plug form 
a strand-~-turn-strand, within which residues 443-445 interface with residues 332-334 in 
the TIM barrel to separate the channel openings. The active site contains a large peak in 
the electron density map that was initially modeled as an octahedrally coordinated 
magnesium atom ligated by four waters and the carboxylates of residues Glu250 and 
Asp278. However, significant positive peaks in the (Fo-Fc) difference electron density 
map at the metal site suggested that instead a calcium ion is bound. Indeed, calcium is 
the major di-cation in the crystallization medium and metal-ligand distances (average 
2.33A) are more consistent with calcium (2.39-2.36 A) than magnesium (2.07 A) (92). 
Crystals identical to those described above were transferred to artificial mother 
liquor in which Ca2+ was replaced by Mg2+ and synchrotron diffraction data were 
collected to 1.04 A resolution (Table 3-2). The final atomic model consists of residues 5­
533,4 Mg2+ ions and 641 water molecules. Many carboxylate and sulfur containing side 
chains have lowered occupancy, presumably due to radiation damage. An anomalous 
scattering difference map exhibited no significant peaks at the presumed metal site, 
indicating that calcium is not present in the magnesium-substituted crystals (data not 
shown). After refinement of the atomic model, the average metal-ligand coordination 
distances is 2.10A, consistent with the replacement ofCa++ with Mg++ (92). The 
remainder of the Mg++-containing model is essentially identical to the Ca++-containing 
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model (rmsd 0.09 A) with the exception of residues 335-343. These form a flexible loop 
with B-factors that are much higher than the average for both structures. 
Active site of ecMSA ternary complex 
The active site of ecMSA is buried between the TIM barrel and the C-terminal 
plug. The electron density map was easily interpreted as containing an octahedrally 
coordinated magnesium ion ligated by two water molecules and one molecule of pyruvate 
or oxalate (see below and Discussion), see Figure 3-1, panel B. Despite the fact that 
pyruvate was included in the crystallization mixture, the electron density map clearly 
shows that the bound species is not planar as expected. The dihedral angle defined by the 
oxygen atoms bound to the metal and intervening carbons refines to a value of -27°. The 
bound species makes hydrogen bonds to the backbone amides of Arg276, Trp277, 
Asp278 and Mg++ as well as to the guanidinium group ofArg166. Three water molecules 
contact the bound species. One is also in contact with the amide nitrogen ofMet330 
while the others contact the guanidinium group of Arg166 and the carboxylate of the 
proposed catalytic base Asp477. Ofparticular interest are the two interactions from 
bound water molecules to the group corresponding to the methyl carbon ofpyruvate, 
which is out of the molecular plane. One involves a very close approach (2.74 A) and is 
thus either a severe steric clash (if a methyl group) or a normal hydrogen bond (if an 
oxygen atom). A second presumed water also makes a contact with this group (3.10 A). 
Since both interactions would be favorable for an oxygen atom, we interpret the bound 
species to be oxalate, rather than pyruvate (see Discussion). If the bound group were 
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indeed pyruvate, there is no obvious explanation for the observed deviation from 
planarity or close contacts of the presumed methyl group with bound solvent molecules. 
Acetyl-CoA binding pocket 
(Acetyl-) coenzyme A is clearly bound to the enzyme, as there is strong, well 
resolved electron density for the adenine ring and ribose. However, density is weaker for 
the phosphate groups, see Figure 3-1, panel C. The adenine ring is sandwiched between 
residues Pr0369 and Metl02. Hydrogen bonds are made between the N6 position of the 
adenine ring and backbone carbonyls of Thr95 and Ala367. Asnl05 makes contacts with 
the ribose hydroxyl and 3'-phosphate. The 3'-phosphate is also bound by Lysl0l and 
Tyr154. The 5'-phosphate is bound by His368. However, density for the panthothenic 
acid tail of acetyl-CoA is too weak to interpret in either protomer within the asymmetric 
unit. This may result from partial hydrolysis or multiple binding conformations (see 
Discussion). Cys438 in the acetyl-CoA binding pocket is clearly oxidized to a cysteine­
sulfenic acid. 
Bacillus anthracis apo form model 
Crystals of Bacillus anthracis malate synthase A (baMSA) grew from ammonium 
sulfate/PEG 4K in space group C2 with unit cell dimensions of a = 97.8 A, b = 52.0 A, c 
= 89.1 A; P= 98.9°. Data reduction statistics were reasonable to 1.70 Aresolution. The 
structure was solved using molecular replacement with the magnesium bound ecMSA 
model after truncation of non conserved residues. The model was constructed using 
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ARP/wARP. The final model has a crystallographic R factor of 0.194 (Rfree = 0.240). 
There is one protomer per asymmetric unit containing residues 7-14, 19-325,345-495, 
497-529, two magnesium ions and 180 water molecules. One of the modeled magnesium 
ions lies in the active site while the other is involved in a crystal contact. The metal ion 
at the crystal contact may actually be a weakly bound Ni2 + ion, as addition ofNiCh to the 
crystallization medium promotes crystal growth. Structural comparison with apo ecMSA 
using DALI results with a rmsd of 1.1 A. Residues 326-344 could not be modeled due to 
a complete lack of density, and in the crystal cannot adopt the conformation of the 
corresponding region of apo ecMSA (residues 329-346) as they would clash with a 
symmetry mate. 
Comparison of apo and ternary ecMSA structures 
Overall comparison. Structural alignment of apo and ternary complex ecMSA 
results in rmsd of 0.69 A for all a-carbons. Upon close inspection, the structures differ 
mostly in the C-terminal plug region. Alignment of the TIM barrel and N-terminal clasp 
portions results in a rmsd of 0.56 A with the C-terminal plug having an a-carbon rmsd of 
0.71 A. The differences in the positions of the C-terminal plug are very likely the result 
of conformational changes due to the presence of an inhibitor in the ternary complex due 
to slight rotations/translations between the domains. 
Loop movement near the active site upon substrate/inhibitor binding. Three loops 
that cluster around the active site exhibit pronounced conformational changes upon 
substrate/inhibitor binding (Figure 3-2). Residues 275-278 form a loop at the pyruvate 
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binding site which switches from an "open" conformation in the apo structure to a 
"closed" conformation with bound inhibitor, shielding the bound species from solvent. In 
the apo form, the backbone atoms of this strand cannot make appropriate interactions 
with the electrophilic substrate, as seen in Figure 3-2. The "open" conformation is 
stabilized by a pocket, formed by the backbone carbonyls of residues 298, 299 and 301, 
in which the guanidine moiety of Arg276 is bound. Upon transitionfrom the "open" to 
"closed" conformation, the guanidine moiety of Arg276 moves ~7 A to a new position, 
where it forms salt bridges with Asp352 and Glu356. As a result, the backbone atoms of 
Arg276 and Trp277 move about 2 A, forming interactions with the bound inhibitor. In 
the closed conformation, Trp277 makes a hydrogen bond to the backbone carbonyl of 
Met330, which moves 1.8 A to meet it. 
C-terminal plug strand-fJ-turn-strand movment. The loop emanating from 
Met330 makes contact with the C-terminal plug strand-p-turn-strand that forms part of 
the acetyl-CoA binding site (Figure 3-2). Ala332 backbone carbonyl makes a hydrogen 
bond to Met445, which is in the acetyl-CoA binding site. Similarly, the Ile334 backbone 
nitrogen contacts the Gly443 carbonyl. It appears that substrate binding induces the 
movement of the loop containing Met445 and Gly443 through the contacts with residues 
330-338 thus widening the entrance to the acetyl binding site. The proposed catalytic 
base (Asp447) which is located at the end of the strand-p-turn-strand, moves about 1A 
away from the electrophilic substrate, possibly making room for the acetyl group as well. 
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Figure 3-2. Overlay of apo and inhibitor bound ecMSA. Panel A. Overview of the 
conformational changes described in the text. Inhibitor bound is in black with apo in 
green. Orange sphere is magnesium. Panel B. Pyruvate binding loop movements. Blue 
sphere represents calcium in apo structure. Panel C. In the apo structure there is a large 
opening between the glyoxylate binding loop and the loop containing Met330. Upon 
inhibitor binding the loop closes up and shields the active site from solvent. 
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Comparison of ecMSG and ecMSA 
Overall structure. The overall fold ofMSA is similar to that described previously 
for MSG. Structural alignment ofthe MSG (PDB entry ID8C) and apo ecMSA 
structures using DALI results in 486 residues aligned with an rmsd of 2.4 Afor a­
carbons. The difference in size between MSG and MSA can be attributed largely to the 
appended alP-domain, which consists of residues 135-262 and 296-333 in MSG. 
Residues 135-252 in MSG can be thought of as an insertion between residues 109-110 in 
MSA and likewise, residues 296-333 form an insertion between residues 158 and 159 in 
MSA. No function has yet been ascribed to the alP-domain ofMSG yet there are 
sequence homologies withinin the family that may give clues to its importance (see 
Discussion). Finally, the N-terminal helical clasp in MSA is shorter by approximately 25 
residues, which in MSG forms two short helices. 
Catalytic site. The active sites of the ternary structures of ecMSA and ecMSG are 
very similar. Alignment of 16 active site a-carbons yields an rmsd of 0.32 A. Notably, 
residues Cys274, Arg276 and Trp277 in ecMSA (corresponding to Thr451 , Phe453 and 
Leu454 in ecMSG) act to form a gate into the active site. These residues are conserved 
within each isoform family even though they are different between the isoforms. 
Interestingly, the active sites of the two isoforms also contain many bound water 
molecules with conserved positions, as shown in Figure 3-3. The catalytic magnesium is 
bound by identical residues in both isoforms. Similarly, the catalytic aspartate and 
arginine are in identical conformations in both isoforms. 
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acetyl-CoA acetyl-CoA 
Figure 3-3. Alignment of ecMSA (black) and ecMSG (magenta) with inhibitors bound. 
Black dashes represent hydrogen bonds and are shown between atoms in ecMSA. The 
blue spheres represent the waters for ecMSA while the red for ecMSG. The green sphere 
is magnesium in ecMSG wile the orange sphere is for ecMSA. 
Acetyl-CoA binding pocket. It is quite interesting that in both MSG and MSA, 
coenzyme A derivatives appear to be disordered and/or only fractionally bound (14, 78, 
82). Acetyl-CoA bound in the ecMSG Anstrom et al. model had B-factors higher than 
the surrounding residues for the panthothenic acid moiety suggesting flexibility. 
Similarly, the panthothenic acid moiety of CoA bound in mTB MSG had high B-factors 
in the models of Smith et aI., whereas in the mTB MSG model of Anstrom et ai. the CoA 
occupancy was lowered. In our ecMSA ternary complex the panthothenic acid moiety is 
not modeled due to weak electron density. Thus, comparison of the binding modes to the 
two isoforms can only be made for the adenine, ribose and phosphate moities of acetyl-
CoA. The defined portion of acetyl-CoA, as modeled in the ecMSA structure, is bound 
in a very similar manner as seen in ecMSG. An alignment between ecMSA and ecMSG 
of nine a-carbons in the acetyl-CoA binding site has an rmsd of 0.57 A. The adenine ring 
sits on top of a proline in both MS, which caps a TIM barrel a-helix in both isoforms, and 
is Pro369 and Pro538 for ecMSA and ecMSG respectively. For isoform A, a conserved 
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methionine at position 102 lies above the ring whereas in ecMSG the residue is Tyr126. 
The N6 position of the adenine ring is bound by backbone carbonyls in both isoforms. In 
both isoforms a conserved asparagine, Asn105 in ecMSA, makes a hydrogen bond to the 
ribose hydroxyl. For MSG the 3'-phosphate is ligated by two arginines whereas in MSA 
these residues are a lysine and tyrosine. The 5' -phosphate is bound by a histidine in 
MSA whereas in MSG the diphosphate interacts with the tyrosine capping the adenine 
ring. One interesting feature is that the conserved ecMSA cys438 in the portion of the 
acetyl-CoA pocket which interacts with the panthothenic acid moiety is oxidized to a 
cysteine-sulfenic acid in both ecMSA and ecMSG inhibitor bound structures (14). 
DISCUSSION 
Given that well diffracting crystals of ecMSG and mTB MSG are difficult to 
obtain, we searched for a MS that would be amenable to structural studies in the hope 
that this would elucidate the conformational changes upon substrate binding and aid in 
structure based drug design. Escherichia coli malate synthase isoform A was found to 
crystallize readily and diffract to high resolution, in addition these crystal forms allowed 
determination of the structure in "open" and "closed" conformations. The "open" 
conformation reveals two openings to the active site and demonstrates how glyoxylate, 
inhibitors and malate enter and exit. Inhibitor binding produces the "closed" 
conformation, for which there is only one opening presumably for acetyl-CoA active site 
access. The closed conformation for ecMSA is similar to that of MS isoform G and 
suggests that transition state analogs will inhibit both. The exact structure of the inhibitor 
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used to obtain the "closed" confonnation remains a question, nevertheless this 
uncertainty does not alter our conclusions concerning confonnational changes and the 
similarities between the active sites of isofonns A and G. 
Oxalate binding 
The presence of oxalate in the ecMSA ternary structure is unexpected as it was 
not included in crystallization, but there is anecdotal evidence that as PEG ages it 
produces oxalate (93-95). Also, Sacchromyces cereviseae MS has a higher affinity for 
oxalate (Kj = 19 ~M) than pryuvate (Kj = 540 ~M) (79), which is likely to be similar for 
ecMSA based on the similarities in pyruvate binding and kinetic constants. Therefore, it 
is likely that oxalate rather than pyruvate is bound in the reported ecMSA ternary 
complex active site. The presence in the active site would have consequences such as on 
the binding of acetyl-CoA. The enolisation reaction of acetyl-CoA by MS has shown to 
be dependent upon th~ presence of 2-keto acids such as pyruvate, as without them it takes 
large quantities of enzyme and high pH to get isotropic exchange with tritiated water. 
This is taken to mean that without a 2-keto acid inhibitor bound the acetyl group of 
acetyl-CoA is not bound effectively for proton abstraction. Interestingly it was found that 
oxalate is deficient in the ability to support the enolization reaction, giving rise to the idea 
that it prevents the acetyl group from binding. 
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Weak acetyl-CoA binding 
In all malate synthase structures analyzed to date low occupancy and disorder of 
bound coenzyme A appears to be a common theme. In the product complex structure of 
mTB MSG, the B-factors for CoA are high and CoA is only observed to be bound to only 
one of the two proteins in the asymmetric unit (78). A recent mTB MSG products bound 
structure also has two protein molecules and only one bound molecule modeled at 70% 
occupancy. The suggested explanation is that crystal contacts inhibit binding for mTB 
MSG. Full occupancy of acetyl-CoA in the ecMSG structure is modeled, but the B­
factors are much higher than the average protein atoms and may reflect flexibility. The 
lack of interpretable electron density for the panthothenic acid moiety of acetyl-CoA in 
the ternary ecMSA structure may be due to the presence of oxalate rather than pyruvate 
in the active site. For ecMSG with acetyl-CoA and pyruvate bound the pyruvate methyl 
group makes hydrophobic interactions with a nearby tryptophan and the terminal sulfur 
of acetyl-CoA, and is bound in a planar fashion. A similar conformation of the acetyl­
group and pyruvate would be expected for ecMSA as in ecMSG due to the similar nature 
of the active sites. Oxalate binding as described before may prevent the binding of the 
acetyl-group of acetyl-CoA, by making hydrogen bonds to the water molecules which are 
bound in the place of the acetyl-group. Unable to have the acetyl-group bind the 
panthothenic acid tail would be free to adopt many conformations outside the binding 
pocket, leading to the weak density seen. 
69 
Structural comparisons and loop movement 
The loop movements seen for ecMSA are large and affect large portions of the 
structure setting up "open" and "closed" forms of the enzyme. It appears that these 
movements are set up to promote the tight binding of glyoxylate before acetyl-CoA. In 
the "open" conformation the cleft into which the panthothenic acid tail would fit is 
partially blocked and would obscure binding of the acetyl group. The phospho-adenosine 
moiety of CoA would still be free to bind in the binding pocket and the tail would be free. 
The open conformation also allows the free binding of glyoxylate. Closing of the 
glyoxylate binding loops is presumed to happen contiguously with the rearrangement 
necessary to open the active site cavity to the acetyl group of acetyl-CoA. It has been 
shown for Zea mays malate synthase (an A isoform) that the affinity for acetyl-CoA is 
increased almost 50 fold when pyruvate is bound in the active site (16). This result 
suggests that the binding of glyoxylate strongly influences the binding of acetyl-CoA. 
These structures may demonstrate the conformational changes involved with the 
increased binding affinity. 
The NMR structure of apo ecMSG (96) may be in agreement with the crystal 
structures in the overall trace of the protein backbone but has very different 
conformations of the side-chains atoms, preventing an accurate comparison to the open 
conformation of ecMSA. Two important residues in the structure, Phe453 and Leu454, 
are shown to be disordered in the apo ecMSG NMR structure. It seems likely that 
Phe453 and Leu454 of ecMSG would undergo a similar conformational change as seen 
70 
for Arg276 and Trp277 in ecMSA to open the active site to the binding of glyoxylate and 
release ofmalate. 
A comparison ofthe ternary and glyoxylate bound structures of ecMSG revels 
movements near the acetyl-CoA binding site in particular Met629 which is on the 
important C-terminal plug strand-~-turn-strand (14). For both isoforms there is a 
conformational change around this conserved residue (Met445 ecMSA), even though the 
length of the loop undergoing this movement is different. The movement of the C­
terminal plug strand-~-turn-strand opens the active site for acetl-CoA entry. The 
decreased activity of baker's yeast MS toward malyl-CoA (97), the intermediate in the 
catalyzed reaction, may be partially due to the lack of accessibility to the active site. 
Previously the lowered reactivity was suggested to be due to a necessary difficult 
deprotonation of the 2-hydroxyl of the malyl-CoA prior to binding (13, 98). 
Possible alp-domain function 
The function of the a/~-domain of MSG has not been reported, and though some 
of its residues are close none directly participate in acetyl-CoA binding. The domain 
may be regulatory or it may serve as an protein-protein interaction scaffold. Dali 
searches using only the a/~-domain do not return results other than MSG, indicating it is 
a novel fold. The first thirteen amino acids (ecMSG 134-146) of the domain are 
conserved between the G isoforms, these residues may be conserved because they are 
adjacent to the helix which binds the adenine moiety of CoA, or may have another 
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purpose such as binding regulatory molecules, as there is a cleft that is formed near these 
residues. 
Inhibition of MS and structural considerations 
Substrate analogs have been previously shown to inhibit the catalysis ofvarious 
malate synthases. Unfortunately most of these inhibitors are substrates for other enzymes 
(glycolate, pyruvate, oxaloacetate or phosphoenolpyruvate) or would harm patients such 
as oxalate or fluoroacetate (16, 78, 79). One goal of this project is to use structures to 
find an effective inhibitor against harmful microbes. Presumed inhibitors designed 
against the active site ofMSG were analyzed against both MS isoforms and found to be 
effective against both isoforms demonstrating that inhibitors designed against one 
isoform will work on the other. Further support is the observation that the active sites 
with inhibitors/substrates bound are very similar. Since ecMSA crystallizes much more 
readily than the MSGs to date or baMSA, it appears that ecMSA is a good choice for 
continuing efforts to develop inhibitors based on structural studies. The apo ecMSA 
structure also allows the design of inhibitors against the "open" conformation. Initially, 
many unsuccessful attempts were made to obtain crystals of ecMSA with substrates or 
inhibitors bound by soaking them into crystals of apo ecMSA, the conformational 
changes associated with binding of substrate/inhibitors may be inhibited by the crystal. 
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CHAPTER IV 
CONCLUSIONS AND FUTURE DIRECTIONS 
We have successfully introduced large conformational changes into roGFPl to 
create the roGFP1-iX family of redox sensors and determined the conformational 
changes necessary for the catalysis of Escherichia coli malate sythase isoform A. Each 
of these projects has further shown the importance of conformational changes to protein 
function, especially with regard to two-state conformational changes near active centers. 
Previous attempts to raise the redox potential of roGFP had marginal success. 
The insertion mutation was a rather drastic measure taken to produce a redox biosensor 
with the thermodynamic properties we needed, and in the end was successful. Insertion 
of a residue next to the disulfide of roGFP introduced strain into the disulfide, not 
directly, but through the necessity of the formation of a cis-peptide bond. The formation 
of the cis-peptide was unexpected, as was the large distance between the cysteines in the 
reduced state. It is unlikely that if such a structure were seen originally for GFP one 
would attempt to make a disulfide bond where it currently exists in roGFP1-iX. It 
appears that the inherent flexibility of the 147 strand containing the disulfide is necessary 
for the formation of the disulfide bond. This begs the question, what effect will prolines 
around the disulfide have on the redox potential? The anomalous redox potential of 
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roGFPI-iR compared to roGFPI-iE was explained by specific interactions in the case of 
roGFP-iR. Will the redox potential change in the expected direction if the specific 
interactions are removed? Other questions remain as well. The most important facing 
the roGFPI-iX indicators is whether they will work in vivo and ifso will the be oxidizing 
enough to measure the thiol/disulfide equilibrium of the endoplasmic reticulum? Ifnot 
useful in the endoplasmic reticulum, the structures ofroGFP-iX can be used to rationally 
explore additional mutations to develop more oxidizing mutants. Incorporation of Mark 
Cannon's positive mutations (44) might lead to increases in redox potential and would be 
beneficial just for the rate enhancement. The information gained from the studies of 
roGFPI-iX will both allow for the further design of conformational changes in redox 
biosensors as well as in other biosensors using similar strategies. In the end, this study 
reveals that conformational changes are a very important part of determining the 
thiol/disulfide equilibrium in proteins. 
Although the goal of the work on malate synthase is to produce drugs to combat 
microbial infections, elucidation of the structural changes of substrate binding gives 
insight into the development of such drugs. Parabanic acid was shown to be an inhibitor 
ofmalate synthase at micromolar concentrations. In theory, this inhibitor is easily 
functionalized. Since crystals of apo ecMSA crack when exposed to the substrate 
glyoxylate, one could functionalize parabanic acid with many different groups and test 
for tight binding to the closed state using the cracking ofcrystals as a screening 
procedure. If this procedure works, the usefulness of conformational changes would be 
demonstrated, not only from a cellular point ofview, but also from one of our own. 
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